Box | Folder		Title
		Series II: Experiment Data, 1949-2003 [series]:
		Experiments by Series, 1949-2003 [subseries]:
		AE series, 1975
2	22	AE1, 4/3/1975
2	23	AE2, 4/4/1975
2	24	AE3(discarded), 4/9/1975
2	25	AE4, 4/10/1975
2	26	AE5, 4/14/1975
2	27	AE6, 4/17/1975
2	28	AE7, 4/28/1975
2	29	AE8, 5/7/1975
2	30	AE9, 5/8/1975
2	31	AE10, 5/19/1975
2	32	AE11 (discarded), 5/20/1975
2	33	AE12, 5/22/1975
		AMP series, 1976
2	34	AMP -- behavior, 1976
2	35	D-AMP-DG-1, 6/8/1976
2	36	D-AMP-DG-2, 6/16/1976
2	37	D-AMP-DG-3, 6/18/1976
2	38	D-AMP-4, 8/26/1976
2	39	D-AMP-5, 8/26/1976
2	40	D-AMP-6, 9/17/1976
2	41	D-AMP-7, 12/23/1976
2	42	D-AMP-8, 12/23/1976
2	43	D-AMP-DG-101, 6/19/1976
2	44	D-AMP-102, 6/28/1976
2	45	D-AMP-103, 7/3/1976
2	46	D-AMP-104, 7/3/1976
2	47	D-AMP-105, 7/6/1976
2	48	D-AMP-106, 7/7/1976
2	49	D-AMP-107, 7/10/1976
2	50	D-AMP-108, 7/10/1976
2	51	D-AMP-109, 7/20/1976
2	52	GU-BR, 1976
3	1	L-AMP-DG-1, 6/12/1976
3	2	L-AMP-2, 10/22/1976
3	3	L-AMP-3, 12/20/1976
3	4	L-AMP-4, 12/21/1976
3	5	L-AMP-5, 12/22/1976
3	6	L-AMP-6, 12/22/1976
3	7	L-AMP-7, 12/23/1976
3	8	L-AMP-101, 7/12/1976
3	9	L-AMP-102, 7/12/1976
3	10	L-AMP-103, 7/15/1976
3	11	L-AMP-104, 7/17/1976
3	12	L-AMP-105, 7/17/1976
		Antipyrine series, 1969-1976
3	13	Antipyrine [ ]-CBF control 1, 3/29/1976
3	14	Antipyrine [ ]-CBF control 2, 4/2/1976
3	15	Antipyrine [ ]-CBF control 3, 4/3/1976
3	16	Antipyrine c14, [ ]-CBF control 4, 4/5/1976
3	17	Antipyrine c14, [ ]-CBF control 5, 4/6/1976
3	18	Antipyrine C14, [ ]-CBF control 6, 4/7/1976
3	19	Antipyrine partition coefficient in dogs, 1969-1970
3	20	Antipyrine partition coefficient in rats [photograph, negative], 1970
3	21	ARF-8A, LCBF-antip.-1', control, 1975
3	22	Chromatography on antipyrine, undated
3	23	Laplace trsnaforms for antip. Sq. wave, 1975-1976
3	24	Series [ ] -- IOD: IODO-antip. part. coeff. in rats -- data corrected, 1976
3	25	Series [ ] -- IOD; IODO-antip. part. coeff. in rats -- discarded, 1976
3	26	Technical information on IODO-antipyrine, 1976
		AR series, 1974-1975
3	27	AR-1, P-30' -- 60 uc, experimental, 1974
3	28	AR-1A, P-30' -- 60 uc control, 1974
3	29	AR-2, P-30' -- 60 uc, experimentals, 1974
3	30	AR-3, P-30' -- 60 uc, experimentals, 1974
3	31	AR-3A, P-30' -- 60 uc, control, 1974
3	32	AR-4, P-30' -- 80 uc, experimentals, 1974
3	33	AR-4A, P-30' -- 80 uc, control, 1974
3	34	AR-5, P-30' -- 80 uc, experimentals, 1974
3	35	AR-5A, P-30' -- 80 uc, control, 1974
3	36	AR-6, P-30' -- 80 uc, experimentals, 1974
3	37	AR-6A, P-30' -- 80 uc, control, 1974
3	38	AR-7, P-30' -- 80 uc, experimentals, 1974
3	39	AR-8, P-30' -- 80 uc, experimentals, 1974
3	40	AR-9, anesthesia -- P-30' -- 80 uc, experimentals, 1974
3	41	AR-10, anesthesia -- P-30' -- 80 uc, experimentals, 1974
3	42	AR-11, experimentals, 11/6/1975
3	43	AR-12, experimentals, 12/6/1975
3	44	AR-13, experimentals, 7/16/1975
		ARF series, 1974-1976
3	45	ARF1 -- LCBF + BARB, 3/20/1974
3	46	ARF2 -- LCBF + BARB, 3/20/1974
3	47	ARF3 -- LCBF + BARB, 3/21/1974
3	48	ARF4 -- LCBF + BARB, 3/21/1974
3	49	ARF5, LCBF + BARB, 3/23/1974
3	50	ARF-6, 6/16/1975
3	51	ARF-7, 6/19/1975
3	52	ARF-8, 6/23/1975
3	53	ARF-11, 6/21/1976
3	54	ARF-12, 6/21/1976
3	55	ARF-13, 6/23/1976
3	56	ARF-14, 6/23/1976
3	57	ARF-15, 6/30/1976
3	58	ARF-16, 7/6/1976
		ATP series, 1964-1973
3	59	ATP assay protocol, undated
3	60	ATP assays of factor preps., 1966
3	61	Effects of thyroid hormone in vivo on protein biosynthesis -- book 1T, 1964
3	62	Effects of thyroxine in vivo [photographs, negatives], undated
3	63	In vivo effect of T4 on microsomal ATP ase (I), 1971
3	64	In vivo effect of T4 on microsomal ATP ase (2), 1972
3	65	In vivo effect of T4/T3 on microsomal ATP ase (3), 1973
3	66	In vivo effect of T4/T3 on microsomal ATPase (4), 1973
4	1	In vivo experiments, undated
4	2	Microsomal ATP ase -- prep book, 1970
4	3	Microsomal ATP ase 1, Apr.-Oct. 1970
4	4	Microsomal ATP ase 2, Oct. 1970
4	5	Microsomal ATP ase 3, 1971-1972
4	6	Microsomal ATP ase 4, 1972-1973
		Cat series, 1971-1981
4	7	Cat 1, LCGU 30', 1971
4	8	Cat 3, LCGU 35', 1971
4	9	Anest. Cat 4, 1974
4	10	Cat 101, 11/17/1977
4	11	Cat 102, 10/20/1977
4	12	Cat 103, 10/27/1977
4	13	Cat 104, 11/17/1977
4	14	Cat 105, 11/21/1977
4	15	Cat 106, 12/1/1977
4	16	Cat 107, 12/8/1977
4	17	Cat 108, 12/15/1977
4	18	Cat 109, 12/21/1977
4	19	Cat 110, 12/29/1977
4	20	Cat 111, Jan. 12, 1978
4	21	Cat 112, 1/19/1978
4	22	Cat 113, 1/26/1978
4	23	Cat 114, 2/2/1978
4	24	Cat 115, 2/9/1978
4	25	Cat 116, 2/23/1978
4	26	Cat 117, 3/2/1978
4	27	Cat 118, 3/9/1978
4	28	Cat 119, 3/14/978
4	29	Cat 120, 3/16/1978
4	30	Cat 121, 3/23/1978
4	31	Cat 122, 3/24/1978
4	32	Cat 123, 3/28/1978
4	33	Cat 124, 3/29/1978
4	34	Cat awake, rem-4, rem-5, pc-1, 1980
4	35	Cat CBF 2, 1971
4	36	Cat, lumped constant, 1974
4	37	Normal cats, LCBF 1, 1971
4	38	Normal cat CBF 3, 1971
4	39	Normal cat CBF 4, 1971
4	40	Normal cat CBF 5, 1971
4	41	Normal -- CFG cat CBF 6, 1971
4	42	SC-1, r. eye patched + 1 PS (P-45' -- 200 uc), 1973
4	43	SC-1A, both eyes patched (P-45 -- 220 uc), 1973
4	44	Series cat: cats -- 30 min. controls, 1980-1981
4	45	Series SQ, Cat 2 -- 8 -- lumped constant in cats conscious, 1974-1976
4	46	SLC 1 (control for REM), 1975
4	47	SLC-2, control for REM, 1975
4	48	SLC-3, REM sleep cat, 1975
4	49	SLC-4, REM sleep cat, 1975
4	50	SLC-5, REM sleep cat, 1976
4	51	SQ -- Cat 1, anesth., 1974
4	52	SQ -- Cat 2, anesth., 1974
		Cerebral Blood Flow (CBF) series, 1953-1993
5	1	1 NMACO2 -- CBF series -- air breathing control, 1990
5	2	2 NMACO2 -- CBF series, air breathing control, 1990
5	3	3 NMACO2 -- CBF series, 5% CO2 in air, 1990
5	4	4 NMACO2 -- CBF series, 5% CO2 in air, 1990
5	5	5 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1990
5	6	6 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1990
5	7	7 NMACO2 -- CBF series, 5% C02 in air, 1990-1991
5	8	8 NMACO2 -- CBF series -- air breathing control, 1990
5	9	9 NMACO2 -- CBF series -- air + N methyl arginine, 1990
5	10	10 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1990
5	11	11 NMACO2 -- CBF series -- air + N methyl arginine, 1990-1991
5	12	12 NMACO2 -- CBF series -- 5% CO2 in air, 1990-1991
5	13	13 NMACO2 -- CBF series -- 5% CO2 in air, 1990-1991
5	14	14 NMACO2 -- CBF series -- 5% CO2 in air, 1990-1991
5	15	15 NMACO2 -- CBF series -- air + N methyl arginine, 1991
5	16	16 NMACO2 -- CBF series -- air breathing control, 1991
5	17	17 NMACO2 -- CBF series -- air + N methyl arginine, 1991
5	18	18 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5	19	19 NMACO2 -- CBF series -- air breathing control, 1991
5	20	20 NMACO2 -- CBF series -- air + N methyl arginine, 1991
5	21	21 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5	22	22 NMACO2 -- CBF series -- air + N methyl arginine, 1991
5	23	23 NMACO2 -- CBF series -- 5% CO2 in air, 1991
5	24	24 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5	25	25 NMACO2 -- CBF series -- air breathing control, 1991
5	26	26 NMACO2 -- CBFG series -- air + N methyl arginine, 1991
5	27	27 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5	28	28 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5	29	29 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (30 mg/kg), 1991
5	30	30 NMACO2 -- CBF series -- - 5% CO2 + N methyl arginine (30 mg/kg), 1991
5	31	31 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5	32	32 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5	33	33 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5	34	34 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (30 mg/kg), 1991
5	35	35 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (30 mg/kg), 1991
5	36	36 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5	37	37 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5	38	38 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5	39	39 NMACO2 -- CBF series -- air + saline, 1991
5	40	40 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (100 mg/kg), 1991
5	41	41 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5	42	42 NMACO2 -- CBF series -- air + N methyl arginine (100 mg/kg), 1991
5	43	43 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5	44	44 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991
5	45	45 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991
5	46	46 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5	47	47 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5	48	48 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991
5	49	49 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991
5	50	50 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5	51	51 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5	52	52 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991
5	53	53 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5	54	54 NMACO2 -- CBF series -- air + saline, 1991
5	55	55 NMACO2 -- CBF series -- air + saline (eliminated), 1991
5	56	56 NMACO2 -- CBF series -- air + saline, 1991
5	57	57 NMACO2 -- CBF series -- air breathing control, 1991
5	58	58 NMACO2 -- CBF series -- 5% CO2 in air, 1991
5	59	59 NMACO2 -- CBF series -- 5% CO2 in air, 1991
5	60	60 NMACO2 -- CBF series -- air breathing control, 1991
5	61	61 NMACO2 -- CBF series -- air breathing control, 1991
5	62	62 NMACO2 -- CBF series -- 5% CO2 in air, 1991
5	63	63 NMACO2 -- CBF series -- saline + 5% CO2, 1991
5	64	64 NMACO2 -- CBF series -- saline + air, 1991
5	65	65 NMACO2 -- CBF series -- saline + air, 1991
5	66	66 NMACO2 -- CBF series -- saline + 5%CO2, 1991
5	67	67 NMACO2 -- CBF series -- air + NMA (30 mg/kg), 1991
5	68	68 NMACO2 -- CBF series -- air + NMA (10 mg/kg), 1991
5	69	69 NMACO2 -- CBF series --5% CO2 + NMA (10 mg/kg), 1991
5	70	70 NMACO2 -- CBF series -- air + NMA (10 mg/kg), 1991
5	71	71 NMACO2 -- CBF series -- 5% CO2 + NMA (10 mg/kg), 1991
5	72	72 NMACO2 -- CBF series -- air + NMA (10 mg/kg), 1991
5	73	NMA-73, NMA 10 mg/kg + air, 1992
5	74	NMA-74, NMA 10 mg/kg I.V + air, 1992
5	75	NMA-75, NMA 30 mg/kg I.V. + air, 1992
5	76	NMA-76, NMA 10 mg/kg I.V. + 5% CO2, 1992
5	77	77 NTRO-1, CO2 and saline I.V., 1992
5	78	78 NTRO-2, CO2 and nitro, 1992
5	79	79 NTRO-3, air and nitro 30 mg/kg i.v., 1992
5	80	80 NTRO-4, air and nitro, 1992
5	81	81 NTRO-5, CO2 and nitro, 1992
5	82	82 NTRO-6, CO2 and saline i.v., 1992
5	83	83 NTRO-7, CO2 and saline i.v., 1992
6	1	84 NTRO-8, CO2 and nitro, 1992
6	2	85 NTRO-9, air and nitro, 1992
6	3	86 NTRO-10, CO2 and nitro 30 mg/kg i.v., 1992
6	4	87 NTRO-11, air + nitro 30 mg/kg i.v., 1992
6	5	88 NTRO-12, CO2 and nitro 30 mg/kg i.v., 1992
6	6	89 NTRO-13, air and nitro, 1992
6	7	90 NTRO-14, air and nitro, 1992
6	8	91 NTRO-15, CO2 and nitro, 1992
6	9	92 NTRO-16, CO2 and nitro, 1992
6	10	93 NTRO-17, 5% CO2 and nitro 30 mg/kg, 1992
6	11	95 NTRO-19, 5% CO2 and nitro 30 mg/kg i.v., 1992
6	12	96 NTRO-20, nitro-topical, 1992
6	13	97 NTRO-21, nitro-topical, 1992
6	14	98 NTRO-22, nitro-topical, 1992
6	15	98 NTRO-23, nitro-topical, 1992
6	16	100 NTRO-24s, air and nitro 30 mg/kg, 1993
6	17	101 NTRO-25s, air + nitro 30 mg/kg, 1993
6	18	102 NTRO-26s, 5% CO2 and nitro 30 mg/kg i.v., 1993
6	19	103 NTRO-27s, nitro 30 mg/g i.v. and 5% CO2, 1993
6	20	104 (28), CO2 and NTRO, 1993
6	21	105 (29), CO2 and NTRO, 1993
6	22	106 (30), air and NTRO, 1993
6	23	107 (31), air and NTRO, 1993
6	24	NTRO 108, chronic i.p. and CO2, 1993
6	25	NTRO 109, chronic i.p. and CO2, 1993
6	26	NTRO 110, chronic i.p. and air, 1993
6	27	NTRO 111, chronic i.p. and air, 1993
6	28	NTRO 112, chronic i.p. and air, 1993
6	29	NTRO 113, chronic i.p. and CO2, 1993
6	30	NTRO 114, chronic i.p. and CO2, 1993
6	31	NTRO 115, chronic i.p. and CO2, 1993
6	32	NTRO 116, chronic i.p. and air, 1993
6	33	NTRO 117, chronic i.p. and air, 1993
6	34	NTRO 118, chronic i.p. and air, 1993
6	35	NTRO 119, chronic i.p. and CO2, 1993
6	36	NTRO 120, saline chronic i.p. and CO2, 1993
6	37	NTRO 121, saline chronic i.p. and CO2, 1993
6	38	NTRO 122, saline chronic i.p. and air, 1993
6	39	NTRO 123, saline chronic i.p. and air, 1993
6	40	NTRO 124, saline chronic i.p. and air, 1993
6	41	NTRO 125, saline chronic i.p. and CO2, 1993
6	42	NTRO 126, 1993
6	43	NTRO 127, 1993
6	44	NTRO 128, 1993
6	45	NTRO 129, 1993
6	46	NTRO 130, 1993
6	47	NTRO 131, saline chronic i.p. and CO2, 1993
6	48	NTRO 132, saline chronic i.p. and CO2, 1993
6	49	NTRO 133, saline chronic i.p. and CO2, 1993
6	50	14c-NMA distribution, 1993
6	51	Brain tissue NMA assay, 1992
6	52	Calculations for CBF (Kety-Schmidt), undated
6	53	CBF -- ischemia experiments, 1980
6	54	CBF -- LSD -- normals, 1954-1955
6	55	CBF -- n.20 -- normal young, 1957-1958
6	56	CBF -- nitrous oxide -- Pitressin, 1956
6	57	CBF -- nitrous oxide -- children [photographs], 1957
6	58	CBF -- thyroid disease, undated
6	59	CBF aged -- continued, 1956-1957
6	60	CBF exp., undated
6	61	CBF lysergic acid [photographs], 1955
6	62	Cerebral blood flow, 1957-1958
6	63	Cerebral blood flow -- book II, 1954-1957
6	64	Cerebral blood flow 3, 1955
6	65	Changes in CBF during REM sleep (fig. 3) (from Reivitch, et. al.) [slides], 1977
6	66	Chemical assay in NMA study, 1992
6	67	CO2 study -- local CBF, undated
6	68	CBF -- LSD -- schizophrenia, 1954-1955
6	69	KR 79 CBF studies [photographs], 1953-1955
6	70	Local C.B.F III, 1954-1955
6	71	Local C.B.F. II, 1953-1954
6	72	Local C.B.V IV, 1955-1957
152	16	Hyperthyroids/hypothyroids, 1950-1951
152	17	[Thyroid hormones], [c.1950s]
152	18	Norepinephrine studies, 1950-1951
152	19-20	The role of L-Norepinephrine in the treatment of shock, 1953
152	21	Sleep paper, [1952-1953]
152	22	Sleep study, [1950-1951]
152	23	Cerebral blood flow mental exercises, [1952-1954]
6	73	NMA Co2 series, undated
6	74	NMA2DG series: animal 01 control, 1991
6	75	NMA2DG series: animal 02, exp. NMA 3 mg., 1991
6	76	NMA2DG series: animal 3, exp. NMA 3 mg/kg, 1991
6	77	NMA2DG series: animal 4 control, 1991
6	78	NMA2DG series: animal 05, exp. NMA 3mg/kg, 1991
6	79	NMA2DG series: animal 06 control, 1991
6	80	NMA2DG series: animal 07, exp. NMA 3mg/kg, 1991
6	81	NMA2DG series: animal 08 control, 1991
6	82	NMA2DG series: animal 09 control, 1991
6	83	NMA2DG series: animal 10 control (eliminated), 1991
7	1	NMA2DG series: animal 11 control, 1991
7	2	NMA2DG series: animal 12 control, 1991
7	3	NMA2DG series: animal 13 control, 1991
7	4	NMA2DG series: animal 14, exp. NMA 100 mg/kg, 1991
7	5	NMA2DG series: animal 15, exp. NMA 100 mg/kg, 1991
7	6	NMA2DG series: animal 16 control, 1991
7	7	NMA2DG series: animal 17, exp. NMA 100 mg/kg, 1991
7	8	NMA2DG series: animal 18 control, 1991
7	9	NMA2DG series: animal 19, exp. NMA 100 mg/kg, 1991
7	10	NMA2DG series: animal 20, exp. NMA 100 mg/kg, 1991
7	11	NMA2DG series: animal 21, exp. NMA 100 mg/kg, 1991
7	12	NMACO2 summaries, 1992
7	13	NMA-DG, data sheet, 1991-1992
7	14	Regional cerebral blood flow (Tbl 2) (from Reivitch, et. al.), 1977
		CI* series, undated
7	15	Ci *(t)/Cp*(t) v.s stretch time (pulse experiments), 1979
7	16	Ci ct/Cp* vs. real time or stretch time -- weighted average, 1979-1985
7	17	Ci*(t)/Cp*(t) vs. stretch time (pulse experiments), undated
7	18-19	Local tissue 14c concentration (gray) Ci*Ct/Cp* (gray) [folder 1 of 2], 1979-1986
7	20	Local tissue 14c concentration (white) -- Ci ct/Cp* (white), 1975-1985
7	21	Lt Cp*dt -- pulse exp., 1979
7	22	Pulse (mori) -- local Ci* -- ci*/Cp*, 1979-1984
7	23	Square wave experiments -- Ci*(t)/Cp*(t) vs. stretch time -- vs. real time Ci*(t)/Cp*, undated
7	24	Weighted average -- Ci*(t)/Cp*(t) vs. stretch time -- pulse experiments, 1979
		CR series, 1972-1976
7	25	CB-4, B-20 uc -- 45', CO2 -- 86', 1975
7	26	CB-5, B-20 uc -- 45', CO2 -- 86', 1975
7	27	CB-6, Pul. -- 20 uc -- 45', CO2 -- 90', 1975
7	28	CB-7, LCGU-45' -- 30 uc, CO2 -- 75', 1975
7	29	CB-8, discarded, 1975
7	30	CB-9, LCGU -- 45' -- 30 uc, CO2 -- 75', 1975
7	31	Series CRO: 5% CO2, 45' exposure, undated
7	32	CR-1, LCGU + CO2, P-30' 80 uc, 1974
7	33	CR-2, LCGU + CO2, P-30' -- 80 uc, 1974
7	34	CR-3, LCGU + CO2, P-30' -- 80 uc, 1974
7	35	CR-4, LCGU + CO2, P-33' -- 90 uc, 1974
7	36	CR-5, LCGU + CO2, P-30' -- 90 uc, 1974
7	37	CR-101, LCGU -- 30' -- 75 uci, CO2 -- 45', 1975
7	38	CR-102, LCGU -- 30' -- 75 uci, CO2 -- 45', 1975
7	39	CR-103, LCGU -- 30' -- 75 uci, CO2 -- 45', 1975
7	40	CR-104, LCGU -- 30' -- 50 uci, CO2 -- 45', 1975
7	41	CR-105, LCGU -- 30' -- 70 uci, CO2 -- 45', 1975
7	42	CRF-1, 85 uc, LCBF + CO2-74 min., 1974
7	43	CRF-2, 85 uc, LCBF + CO2 -- 70', 1974
7	44	CRF-3, 85 uc, LCBF + CO2 -- 45', 1974
7	45	CRF-4, 68 uc, LCBF + CO2 -- 48', 1974
7	46	CRF-5, 68 uc, LCBF + CO2 -- 45', 1974
7	47	CRF-6, 85 uc, LCBF + CO2 -- 41', 1974
7	48	CRF-7, 85 uc, LCBF + CO2 -- 26', 1974
7	49	CRF-8, 85 uc, LCBF + CO2 -- 38', 1974
7	50	CRF-9, 85 uc, LCBF + CO2 -- 43', 1974
7	51	CRF-10, 85 uc, LCBF + CO2 -- 42', 1974
7	52	CRF-11, 85 uc, LCBF + CO2 -- 11', 1975
7	53	CRF-12, 85 uc, LCBF + CO2 -- 12', 1975
7	54	CRF-13, 85 uc, LCBF + CO2 -- 12', 1975
7	55	CRF-14, 85 uc, LCBF + CO2 -- 16', 1975
7	56	CRF-15, 68 uc, LCBF + CO2 -- 14', 1975
7	57	CRF-101, LCBF -- 1', 10% CO2 -- 45', 1975
7	58	CRF-102, LCBF -- 1', 10% CO2 -- 45', 1975
7	59	CRF-103, LCBF -- 1', 10% CO2 -- 45', 1975
7	60	CRF-104, LCBF -- 1', 10% CO2 -- 45', 1975
7	61	CRF-105, LCBF (Ant. 1'), 10% CO2 -- 45', 1975
7	62	Series CRF 111-115 : 10% CO2 + 10' exposure, 1975
7	63	CRF-201, 20% CO2, 1976
7	64	L.C.B.F. : effects of CO2 in puppy, 1972
		DEX series, 1979
8	1	Dex-1, 1/30/1979
8	2	Dex-2, 3/12/1979
8	3	Dex-3, 3/14/1979
8	4	Dex-4, 3/16/1979
8	5	Dex-5, 4/19/1979
8	6	Dex-Px-1 (21 mg/kg), 1/15/1979
8	7	Dex-Px-2 (21 mg/kg), 3/12/1979
8	8	Dex-Px-3 (21 mg/kg/min.), 3/14/1979
8	9	Dex-Px-4 (21 mg/kg), 3/16/1979
8	10	Dex-Px-5 (21 mg/kg), 3/21/1979
		Deoxyglucose (DG) series, 1973-1979
8	11	% of free DG in grey and white matter, 1977
8	12	DG-1, 30' -- B, 1973
8	13	DG-2 (C14), 1973
8	14	DG-3, 45' cont., 1973
8	15	DG-101, 30' -- B, 1973
8	16	DG-102, B -- 30' -- 51 uc, 1973
8	17	DG-103, B-45'-76 uc, 1973
8	18	DG-104, B-45' -- 76 uc, 1973
8	19	DG-105 B-120' (51 uc x 1 1/2'), 1973
8	20	DG-106, B-45' -- 51 uc, 1973
8	21	DG-107 B-120 (51 uc x 1 1/2'), 1973
8	22	DG-108, B-45' -- 51 uc, 1973
8	23	DG-111, B-75' -- 51 uc, 1973
8	24	DG-112, B-75 -- 51 uc, 1973
8	25	DG-113, B-90' -- 51 uc, 1973
8	26	DG-114, B-90' -- 51 uc, 1973
8	27	DG-115, LCGU -- control 45', 1975
8	28	DG-116, LCGU -- control 45' (30 uc), 1975
8	29	DG-117, LCGU -- 30' -- 50 uc, 1975
8	30	DG-118, LCGU -- 30', control, 1975
8	31	DG-119, LCGU -- 30' -- 50 uc, control, 1975
8	32	DG-120, LCGU -- 30' -- 50 uc, control, 1975
8	33	DG-121, normal control 45', 1976
8	34	DG-125, LCGU normal control rat, 30', 1976
8	35	DG-126, LCGU -- normal control rat 45', 1976
8	36	DG-127, LCGU -- normal control, 45', 1976
8	37	DG-128, LCGU -- normal control rat, 45', 1976
8	38	DG-129, LCGU -- normal control rat, 45', 1976
8	39	DG-130, LCGU -- normal control, 30', 1976
8	40	DG-131, LCGU -- normal control, 30', 1976
8	41	DG-132, LCGU normal control, 30', 1976
8	42	DG-133, LCGU -- normal control, 30', 1976
8	43	DG-134, LCGU -- normal control rat, 45' (discarded), 1976
8	44	DG-135, LCGU -- light flow rate of anesthetic gas mixture, 45', 1976
8	45	DG-137, LCGU -- tight mask + high flow rate of anesthetic gas mixture, 30', 1976
8	46	DG-138, normal control rat, 45', 1976
8	47	DG-141, high flow rate of gas mix with tight mask, 30', 1976
8	48	DG-142, low flow rate of gas mix with loose mask, 30', 1976
8	49	DG-143, normal control rat, 45', 1976
8	50	DG-144, normal control rat, 45', 1976
8	51	DG-145, normal control rat, 45', 1976
8	52	DG-146, normal control rat, 45', 1976
8	53	DG-147, normal control rat, 45' (discarded), 1976
8	54	DG-170, 8/16/1977
8	55	DG-182, 45 min. (C.K.), 7/27/1978
8	56	DG-183, 30 min. (C.K.), 7/27/1978
8	57	DG-184, 20 min. C.K., 7/27/1978
8	58	DG-185, 45 m in. (C.K.), 7/31/1978
8	59	DG-186, 30 min. (C.K.), 7/31/1978
8	60	DG-190, 45 min. (C.K.), 9/11/1978
8	61	DG-191, 20' control, 9/11/1978
8	62	DG-192, 60 min. (C.K.), 9/14/1978
8	63	DG-193, 45 min. (C.K.), 9/18/1978
8	64	DG-194, 90 min. (C.K.), 9/21/1978
8	65	DG-195, 20 min. C.K., 9/21/1978
8	66	DG-196, 20 min. C.K., 10/2/1978
8	67	DG-198, 30 min. (C.K.), 10/5/1978
8	68	DG-199, 20 min. C.K., 10/16/1978
9	1	DG-200, 30 min (C.K.), 10/16/1978
9	2	DG-201, 45 min. (C.K.), 10/19/1978
9	3	DG-201, 5' -- C -- 51 uc, 1973
9	4	DG-202, 60 min (C.K.), 10/19/1978
9	5	DG-202., 5' -- C -- 51 uc, 1973
9	6	DG-203, 10' -- C 39 uc, 1973
9	7	DG-203, 90 min., 10/23/1978
9	8	DG-204, 10' -- C 39 uc, 1973
9	9	DG-204, 60 min., 10/23/1978
9	10	DG-205, 10' -- C -- 39 uc, 1973
9	11	DG-205, 60 min. control, 1978
9	12	DG-206, 5' -- C 51 uc, 1973
9	13	DG-207, 10' -- C -- 39 uc, 1973
9	14	DG-207, 60 min., 12/22/1978
9	15	DG-208, 20' -- C -- 34 uc, 1973
9	16	DG-209, 20' -- C -- 34 uc, 1973
9	17	DG-209, 45 min. (C.K.), 12/28/1978
9	18	DG-210, 20' -- C -- 34 uc, 1973
9	19	DG-210, 30 min., 12/28/1978
9	20	DG-211, 20 min. control, 1/4/1979
9	21	DG-211, C -- 30' -- 29 uc, 1973
9	22	DG-212, 30' -- C -- 29 uc, 1973
9	23	DG-212, 90 min., 1/11/1979
9	24	DG-213, 90 min., 1/15/1979
9	25	DG-213, C -- 30' -- 29 uc, 1973
9	26	DG-214, 90 min., 1/18/1979
9	27	DG-214, C -- 45' -- 23 uc, 1973
9	28	DG-215, 90 min., 1/18/1979
9	29	DG-215, C -- 45' -- 23 uc, 1973
9	30	DG-216, C -- 1' -- 68 uc, 1973
9	31	DGX-1, BoP. -- 6 hrs., 1973
9	32	DGX-2, BoP. -- 17 hrs., 1973
9	33	DGX-3, BoP -- 24 hrs., 1973
9	34	Summary of DGX-1, DGX-2, DGX-3 data, 1973
151	4	[DG* and DG*-6-P chart with three time graph printouts, 1974, 1975, 1976
		DL series, 1971-1973
9	35	DL-X, 1972
9	36	Series DL1 -- DL11 : 20 mg/kg, experimentals, 1971
9	37	Series DL 1A -- DL 11A : 20 mg/kg controls, 1972
9	38	Series DL101 -- DL110 : 100 mg/kg, experimentals, 1971
9	39	Series DL201-DL206 : 50 mg/kg, experimental, 1972
9	40	Series DL207A -- DL215A : 50 mg/kg, controls, 1972
9	41	Series DL208 -- DL211 : 50 mg/kg, experimentals, 1972
9	42	Series DL213 -- DL214 : 50 mg/kg, experimentals, 1975
9	43	Series DL301 and DL302 : 50 mg/kg, experimental, 1972
9	44	Series DL301A -- DL303A : 50 mg/kg, controls, 1972
9	45	Series DL304 -- DL307 : 50 mg/kg, experimentals, 1972
9	46	Series DL306A -- DL309A : 50 mg/kg, controls, 1972-1973
9	47	Series DL-309 : 50 mg/kg, experimentals, 1973
		E/E series, 1974-1975
9	48	E/E 1and2, discarded, 1974
9	49	E/E 3, 1974
9	50	E/E 4, 1974
9	51	E/E 5, 1974
9	52	E/E 6, 1974
9	53	Rat E/E 7, 1974
9	54	E/E 8, 11/7/1974
9	55	E/E 9, 11/14/1974
9	56	E/E 10, 12/12/1974
9	57	E/E 11, 1974
9	58	E/E 12, 1974
9	59	E/E 13, Jan. 10, 1975
9	60	E/E 14, 1/13/1975
9	61	E/E 15, 1/17/1975
9	62	E/E 16, 1/23/1975
9	63	E/E 17, 1/27/1975
9	64	E/E 18, 2/6/1975
9	65	E/E 19, 2/10/1975
9	66	E/E 20, 2/13/1975
9	67	E/E 21, Feb. 14, 1975
9	68	E/E 26, and 27, cancelled, 1975
9	69	E/E 29 discarded, 1975
		G6 series, 1985, 1987
9	70	G6 pase 1, 1985
9	71	G6 pase 2, 1985
9	72	G6 pase 3, 1985
9	73	G6 pase 4, 1985
9	74	G6 pase 5, 1985
9	75	G6 pase 6, 1985
9	76	GA pase 7, 1985
9	77	G6 pase 8, 1985
9	78	G6 pase 9, 1985
9	79	G6 pase 10, 1985
9	80	G6 pase 11, 1985
9	81	G6 pase 12, 1985
9	82	G6 pase 13, 8/2/1985
9	83	G6 pase 14, 1985
9	84	G6 pase 15, 1985
9	85	G6 pase 16, 1985
9	86	G6 0ase 17, 8/5/1985
9	87	G6 pase 18, 8/5/1985
9	88	G6 pase 19, 8/5/1985
9	89	G6 pase 20, 8/5/1985
9	90	G6 pase 21, 8/1/1985
9	91	G6 pase 22, 8/6/1985
9	92	G6 pase 23, 8/6/1985
9	93	G6 pase 24, 8/6/1985
9	94	G6 pase 25, 8/7/1985
9	95	G6 pase 26, 8/7/1985
9	96	G6 pase 27, 8/7/1985
9	97	G6 pase 28, 8/7/1985
9	98	G6 pase 29, 8/8/1985
10	1	G6 pase 30, 8/8/1985
10	2	G6 pase 31, 8/8/1985
10	3	G6 pase 32, 8/8/1985
10	4	G6 pase 33, 8/9/1985
10	5	G6 pase 34, 8/9/1985
10	6	G6 pase 35, 8/9/1985
10	7	G6 pase 36, 8/9/1985
10	8	G6 pase 37, 8/10/1985
10	9	G6 pase 38, 8/10/1985
10	10	G6 pase 39, 1985
10	11	G6 pase 40, 1985
10	12	G6 pase 41, 1985
10	13	G6 pase 42 -- 60 min., 8/13/1985
10	14	G6 pase 43, 1985
10	15	G6 pase 44, 8/14/1985
10	16	G6 pase 45 -- 90 min., 8/14/1985
10	17	G6 pase 46 -- 2.5 min., 8/14/1985
10	18	G6 pase 47 -- 15 min., 8/14/1985
10	19	G6 pase 48 -- 60 min., 8/16/1985
10	20	G6 pase 49 -- 30 min., 8/16/1985
10	21	G6 pase 50 -- 15 min., 8/16/1985
10	22	G6 pase 51, 8/17/1985
10	23	G6 pase 52, 10/16/1985
10	24	G6 pase 53, 10/16/1985
10	25	G6 pase 54, 11/27/1985
10	26	G6 pase 55, 11/27/1985
10	27	G6 pase 56, 11/29/1985
10	28	G6 pase 57, 11/29/1985
10	29	G6 pase 58, 11/29/1985
10	30	G6 pase P1, 8/15/1985
10	31	G6 pase P2, 8/15/1985
10	32	G6 pase P3, 8/16/1985
10	33	G6 pase P4, 8/16/1985
10	34	G6 pase P5, 8/16/1985
10	35	G6 pase P6, 8/27/1985
10	36	G6 pase P7, 8/1985
10	37	G6 pase, 1985
10	38	G6 pase -- vol. I -- no. 1 -- no. 13, 1985
10	39	G6 pase -- vol. II -- no. 14 -- no. 25, 1985
10	40	G6 pase -- vol. III -- no. 26 -- no. 37, 1985
10	41	G6 pase -- vol. IV -- no. 38 -- no. 49, 1985
10	42	G6 pase -- P -- vol V, 1985
10	43	G6 pase -- vol. VI -- no. 50, 1985
10	44	G6 pase (square) -- anova, 1987
10	45	Physiological conditions -- G6 pase 1~58, undated
		HLNC series, 1976
10	46	Helen and Larry normal control series, undated
10	47	HLNC-DG-, 6/25/1976
10	48	HLNC-DG-2, discarded, 6/25/1976
10	49	HLNC-3, 6/28/1976
10	50	HLNC-4, 7/1/1976
10	51	HLNC-5, 7/2/1976
10	52	HLNC-6, 7/6/1976
10	53	HLNC-7, 7/10/1976
10	54	HLNC-8, 8/24/1976
10	55	HLNC-9, 8/24/1976
10	56	HLNC-10, 10/22/1976
10	57	HLNC-11, 12/18/1976
10	58	HLNC-12, 12/18/1976
10	59	HLNC-13, 12/20/1976
10	60	HLNC-14, 12/21/1976
10	61	HLNC-15, 12/22/1976
		HIG series, 1977-1978
10	62	HIG-1, 11/28/1977
10	63	HIG-2, 11/28/1977
10	64	HIG-3, 12/2/1977
10	65	HIG-4, 5/11/1978
10	66	HIG-5, 5/31/1978
10	67	HIG-NS-1, 1/11/1978
10	68	HIG-saline-2, 2/7/1978
10	69	HIG-saline-9, 7/12/1978
11	1	Nacl-01, 6/22/1978
11	2	Nacl-03, 7/10/1978
11	3	Nacl-04, 7/11/1978
11	4	Nacl-05, 7/12/1978
11	5	Nacl-3, 2/13/1978
11	6	Nacl-4, 2/22/1978
11	7	Nacl-5, 4/4/1978
11	8	Nacl-6, 4/18/1978
11	9	Nacl-7, 5/3/1978
11	10	Nacl-8, 5/10/1978
		Hyperglycemia (LC) series, 1980-1987
11	11	LC -- hyperglycemia 1, 1/15/1980
11	12	LC -- hyperglycemia 2, 1/28/1980
11	13	LC -- hyperglycemia 3, 2/1/1980
11	14	LC -- hyperglycemia 4, 12/3/980
11	15	LC -- hyperglycemia 5 -- Franz, Francesco, Jane, Esther, Sumio, 2/6/1980
11	16	LC -- hyperglycemia 6, 2/20/1980
11	17	LC -- hyperglycemia 7 -- Franz, Francesco, Jane, Esther, Sumio, 3/3/1980
11	18	LC -- hyperglycemia 8 -- Franz, Francesco, Sumio, Dr. Kennedy, Wolfgang, Jane Jehle, Esther, 3/12/1980
11	19	LC -- hyperglyc. 9 -- Franz, Francesco, Sumio, Jane, Dr. Kennedy, Wolfgang, Esther, 3/18/1980
11	20	LC -- hyperglycemia 10 -- Franz, Francesco, Sumio, Esther, Wolfgang, Dr. Kennedy, 3/27/1980
11	21	LC -- hyperglycemia 11 -- Franz, Francesco, Sumio, Dr. Kennedy, Wolfgang, Jane, 3/31/1980
11	22	LC -- hyperglycemia 12 -- Franz, Francesco, Sumio, Jane Jehle, Esther, 4/22/1980
11	23	LC -- hyperglycemia 13 -- Franz, Francesco, Sumio, Jane, Esther, 4/29/1980
11	24	LC -- hyperglycemia 14 -- Franz, Francesco, Sumio, Jane, Esther, 5/6/1980
11	25	LC -- hyperglycemia 15 -- Franz, Francesco, Sumio, Jane, Esther, 5/8/1980
11	26	LC -- hyperglycemia 16 -- Franz, Francesco, Jane, Esther, 5/13/1980
11	27	LC -- hyperglycemia 17 -- Franz, Francesco, Sumio, Jane, Esther, 5/19/1980
11	28	LC -- hyperglycemia 18 -- Franz, Francesco, Sumio, Jane, 5/21/1980
11	29	LC -- hyperglycemia 19 -- Franz, Francesco, Sumio, Jane, Esther, 5/23/1980
11	30	LC -- hyperglycemia 20 -- Franz, Francesco, Jane, Sumio, Esther, 5/30/1980
11	31	LC -- hyperglycemia 21 -- Franz, Francesco, Jane, Sumio, 5/30/1980
11	32	LC -- hyperglycemia 22 -- Franz, Francesco, Jane, 6/9/1980
11	33	LC -- hyperglycemia 23 -- Franz, Francesco, Jane, 6/11/1980
11	34	LC -- hyperglycemia 24 -- Franz, Francesco, Jane, 6/16/1980
11	35	LC -- hyperglycemia 25 -- Franz, Francesco, Jane, 6/19/1980
11	36	LC -- hyperglycemia 26 -- Franz, Francesco, Jane, 6/25/980
11	37	LC -- hyperglycemia 27 -- Franz, Francesco, Jane, Esther, 7/1/1980
11	38	LC -- hyperglycemia 28 -- Franz, Francesco, Sumio, Jane, Esther, 7/8/1980
11	39	LC -- hyperglycemia 29 -- Franz, Francesco, Jane, Esther, 7/10/1980
11	40	LC -- hyperglycemia 30 -- Franz, Francesco, Jane, Esther, 7/17/1980
11	41	LC -- hyperglycemia 31 -- Franz, Francesco, Jane, Esther, 7/21/1980
11	42	LC -- hyperglycemia 32 -- Franz, Francesco, Jane, Sumio, Esther, 7/24/1980
11	43	LC- hyperglycemia -- compiled data, 1980-1987
11	44	LC -- hyperglycemia -- error analyses, counting procedures, etc., 1980
11	45	LC table -- species, undated
		Iodoantipyrine (IOD) series, 1976-1977
11	46	Iodoantipyrine [ ]-CBF control 1, 4/1/1976
11	47	Iodoantipyrine [ ]-CBF control 2, 4/2/1976
11	48	Iodoantipyrine [ ]-CBF control 3, 4/3/1976
11	49	14c -- iodoantiyprine, [ ]-CBF control 4, 4/6/1976
11	50	14c -- iodoantipyrine, [ ]-CBF control 5, 4/6/1976
11	51	14c -- iodoantipyrine -- [ ]-CBF control 6, 4/7/1976
11	52	Chromatography for 14c -- iodoantipyrine, 7/7/1976
11	53	Chromatography of iodoantipyrin experiment -- by J. D. Brown, 1976
11	54	Dissolve of 14c -- iodoantipyrine into dioxane phosphov., undated
11	55	IOD-C-7, 14c iodoantiyprine normal cat, 8/19/1976
11	56	IOD-C-8, 1/6/1977
11	57	Iodoantipyrine cat normal control 1, 5/6/1976
11	58	Iodoantipyrine cat normal control 2, 5/14/1976
11	59	Iodoantipyrine normal CBF cat 3, 5/20/1976
11	60	Iodoantipyrine normal control 4, 5/27/1976
11	61	Iodoantipyrine cat normal control 5, 6/4/1976
11	62	Iodoantipyrine cat normal control 6, 6/11/1976
11	63	Iodoantipyrine cat study summary, undated
11	64	Iodoantipyrine solubility property, undated
11	65	Iodoantipyrine study summary, undated
11	66	Iodoantipyrine, radiochromatogram -- CFG 1265, 1976
11	67	Iodoantipyrine, radiochromatogram -- CFQ 1460, 1976
		IP series, 1993
11	68	IPBF 1-4, 1993
11	69	IPBF 5-8, 1993
11	70	IPBF 9-12, 1993
11	71	IPBF 13-16, 1993
11	72	IPBF 17-20, 1993
12	1	IPBF 21-24, 1993
12	2	IPBF 25-28, 1994
12	3	IPBF 29-32, 1994
12	4	IPDG 2 L-NAME, 1993
12	5	IPDG 3 L-NAME, 1993
12	6	IPDG 4 saline, 1993
12	7	IPDG 5, saline, 1993
12	8	IPDG 6, L-NAME, 1993
12	9	IPDG 7, L-NAME, 1993
12	10	IPDG 8, saline, 1993
12	11	IPDG 9, saline, 1993
12	12	IPDG 10, L-NAME, 1993
12	13	IPDG 11, saline, 1993
12	14	IPDG 12, saline, 1993
12	15	IPDG 13, L-NAME, 1993
12	16	IPDG 14, saline, 1993
12	17	IPDG 15, saline, 1993
12	18	IPDG 16, L-NAME, 1993
12	19	IPDG 17, saline, 1993
12	20	IPDG 18, saline, 1993
		KSA series, 1975-1976
12	21	Antipyrine chromatography, KSA 101 and 102 (plasma), 1975
12	22	Series KSA-0: antipyrine for BDBF pulse inf. for laplace transf., undated
12	23	KSA-101, CBF (K-s) antipyrine, sq. wave 60', 1975
12	24	KSA-102, CBF (K-S) antipyrine, sq. wave 35', 1975
12	25	KSA-103, CBF (K-S) antipyrine, pulse-50 uc-60', 1975
12	26	KSA-103: chromatography on plasma and brain, 1976
12	27	KSA-104 and 105, in brain and plasma, 1976
12	28	KSA-104, discarded, 1976
12	29	KSA-105, discarded, 1976
12	30	KSA-106, discarded, 1976
12	31	KSA-107, discarded, 1976
12	32	KSA-108, discarded, undated
12	33	KSA-109, discarded, 1976
12	34	KSA-110, discarded, 1976
12	35	KSA-114, discarded, 1976
12	35	KSA-118, discarded, 1976
12	37	KSA-119, discarded, 1976
12	38	KSA-120, discarded, 1976
12	39	KSA-124, undated
12	40	KSA-127, discarded, 1976
12	41	KSA-128, discarded, 1977
12	42	KSA-129, normal control (immobilization), 1977
12	43	KSA-131, 5% CO2, CBF, 1977
12	44	KSA-132, normal control, 1977
12	45	KSM-101, methylglucose as tracer for GCBF, 1975
12	46	KSM-102, methylglucose as tracer for GCBF, 1975
12	47	Series KSH: hippuric acid as tracer for GCBF, 1976
12	48	Series KSM1 -- KSM3: methylglucose as tracer for GCBF, 1975
		Lidocaine (Lido) series, 1978-1979
12	49	Lido-1, control, 7/24/1978
12	50	Lido-1', 7/24/1978
12	51	Lido-2, 8/3/1978
12	52	Lido-3, 2 lidocaine, 8/10/1978
12	53	Lido-4, 1 lidocaine, 8/10/1978
12	54	Lido-5, saline control, 1/11/1979
12	55	Lido-5', no seizure history, 1/11/1979
12	56	Lido-6, saline, 1/12/1979
12	57	Lido-6', lidocaine, 1/12/1979
12	58	Lido-7, saline, 1/19/1979
12	59	Lido-7', lidocaine, 1/19/1979
12	60	Lido-8, saline, 1/25/1979
12	61	Lido-8', lidocaine, 1/25/1979
12	62	Lido-9, saline, 1/26/1979
12	63	Lido-9' (experimental animal), 1/26/1979
12	64	Lido-10, saline control, 2/1/1979
12	65	Lido-10', lidocaine, 2/1/1979
12	66	Lido-11, saline control, 2/2/1979
12	67	Lido-11', lidocaine, 2/2/1979
12	68	Lido-12, saline, 2/15/1979
12	69	Lido-12', lidocaine, 2/15/1979
12	70	Lido-13, saline, 2/16/1979
12	71	Lido-13', lidocaine, 2/16/1979
12	72	Lidocaine summary, 1979
		Glucose Utilization (LCGU) series, 1977-1987
12	73	Cerebral structure w/ signif. changes in LCGU at higher doses of D-LSD, 1976-1977
12	74	Effects of LSD on LCGU in individual structures as a function of dose, undated
12	75	Experiments -- hyperglycemia R.C. average, 1984
12	76	Free moving immobilization on LCGU and LCBF, 1978
12	77	Glucose / LCGU : from 0' -- 120', undated
12	78	Hyperglycemia LCGU experiments -- excluded and misc., 1980-1982
13	1	Hyperglycemia LCGU experiments -- excluded and misc. [cont'd.], 1980-1982
13	2	Hyperglycemia LCGU experiments -- used and tables, 1982
13	3	Hyperglycemia LCGU experiments 450, 1984
13	4	Hyperglycemia LCGU experiments 450 (programming changes), 1984
13	5	Hyperglycemia LCGU experiments 550A, 1984
13	6	Hyperglycemia, 2DG, 450's, 1984
13	7	L.C.G.U. (pulse exp.) parameters: new 3 rate constants, 1986
13	8	L.C.G.U. (pulse experiments) from Dr. Shinohara's data representative structures, 1977
13	9	LCGU -- pulse experiments -- LC=0.483 -- parameters: new 3 rate constants, 1986
13	10	LCGU -- sandro, undated
13	11	LCGU -- taro, undated
13	12	LCGU (pulse experiments) -- 5 rate constants (K4*=0.002), 1986
13	13	LCGU (pulse experiments) Shinohara series -- graphs -- representative structures, 1977
13	14	LCGU (pulse) parameters 5 rate constants (K4*=0.0014), 1986
13	15	LCGU (square exp.) parameters 5 rate constants (K4*=0.001), 1986
13	16	LCGU (square wave experiments) graphs, undated
13	17	LCGU (square wave experiments) gray structures, undated
13	18	LCGU (square wave experiments) white structures, undated
13	19	LCGU hyperglycemia experiments -- Franz, Francesco, 1980
13	20	LCGU pulse experiments -- 5 rate constants (K4*=0.001), 1986
13	21-23	Local Cerebral Glucose Utilization, 1987
13	24	Shinohara pulse data -- LCGU w/5 -- H model -- K4=.002, K5=.05, 1986
13	25	Spinal cord (sleep) -- LCGU, undated
13	26	Summary of LCGU (pulse) with original rate constants, 1987
13	27	Summary of local LCGU -- square wave exp., undated
13	28	Table for LCGU value, undated
13	29	The effect of NMA on LCGU in the rat, undated
13	30	Weighted average LCGU -- pulse experiments, undated
		LS series, 1977-1979
14	1	LS-11, general, 8/29/1978
14	2	LS-II-1, 1977
14	3	LS-II-2, 11/8/1977
14	4	LS-II-3, 11/8/1977
14	5	LS-II-4, 11/8/1977
14	6	LS-II-5, 11/10/1977
14	7	LS-II-6, 11/11/1977
14	8	LS-II-7, 11/11/1977
14	9	LS-II-8, 12/9/1977
14	10	LS-II-9, 12/9/1977
14	11	LS-II-10, 12/9/1977
14	12	LS-II-11,12,13, 2/24/1978
14	13	LS-II-14,15,16, 4/3/1978
14	14	LS-II-17, 4/7/1978
14	15	LSB-2, 1979
14	16	LSB-3, 1977
14	17	LSB-4, 1977
14	18	LSB-5, 1977
14	19	LSB6-10, 1977
		MG series, 1973, 1988-1989
14	20	Extracting rat brain containing 3H-MG with hexane and chloroform by H. Nakanishi, 1988-1989
14	21	HIGH std.-2, 14c-MG, 10/2/1978
14	22	HIGH-STD-3, 14c-MG, 10/2/1978
14	23	MG and hypothalam atlas [computer disk], undated
14	24	MG series '73, 1973
14	25	MG-1, 5' cont., 1973
14	26	MG-2, 10' -- cont., 1973
14	27	MG-3, 20' -- cont., 1973
14	28	MG-4, 30' -- cont., 1973
14	29	MG-5 (C14), 2 hrs., 1973
14	30	MG-6 (C14), 1 min., 1973
14	31	MG 7 (C14), 15' cont., 1973
14	32	MG-8 (C14), 60' cont., 1973
14	33	MG-9, 45' cont., 1973
14	34	MG-10 (C14), 4' -- cont., 1973
14	35	MG-11 (C14), 45' -- cont., 1973
14	36	MG-12 (C14), 40' -- bol. C.S.F., 1973
14	37	MG-13 (C14), 4' -- cont., 1973
14	38	MG-14 (C14), 50' -- bol. C.S.F., 1973
14	39	MG-15, 75' -- bol. C.S.F., 1973
14	40	MG-16, 120' -- bol. C.S.F., 1973
14	41	MG-17, 60' -- bol. C.S.F., 1973
14	42	MG-18, 240' -- bol. C.S.F., 1973
14	43	MG-101 and 102, 30' -- B -- 51 u., 1973
14	44	MG-103 and 104, 45' -- B -- 76 uc., 1973
14	45	MG-105, B -- 120' -- 51 uc., 1973
14	46	MG-106 and 107, B -- 45' -- 51 uc., 1973
14	47	MG-108, B -- 120' -- 51 uc., 1973
14	48	MG-109 and 110, B -- 60 -- 51 uc., 1973
14	49	MG-111 and 112, B -- 75' -- 51 uc., 1973
14	50	MG-113 and 114, B -- 90' -- 51 uc., 1973
		MSG series, 1978
14	51	MSG-01, 6/22/1978
14	52	MSG-03, 7/10/1978
14	53	MSG-04, 7/11/1978
14	54	MSG-05, 7/11/1978
14	55	MSG-06, 7/12/1978
14	56	MSG-07 (experiment stop), 7/12/1978
14	57	MSG-1, 1/11/1978
14	58	MSG-2, 2/7/1978
14	59	MSG-3, 2/13/1978
14	60	MSG-4, 2/25/1978
14	61	MSG-5, 4/4/1978
14	62	MSG-6, 4/18/1978
14	63	MSG-7, 5/3/1978
		Radioactive isotope studies
152	7	Correspondence - miscellaneous, [1951-1952]
152	8	Radioactivity work, [c.1950]
152	9	Phosphorous 32, [c.1952]
152	10	Radioactive iodine - I131, [c.1952]
152	11	Radioactive Krypton, [1951]
152	12	Krypton study, [1952]
152	13	[Investigation of effectiveness of circulation and radioactive isotope tracers], [c.1950s]
		Na24 series, 1956-1957
152	14	[Radioactive Sodium [Na24] USPHS study], [1951-1953]
152	15	Na24 clearance with perfusion in dogs with blood flow determinations, [1953]
14	64	[patient name redacted] -- LBF -- Na24, 1956
14	65	[patient name redacted] -- LBF -- Na24, 1956
14	66	[patient name redacted] -- LBF -- Na24, 1957
14	67	[patient name redacted] -- LBF -- Na24, 1956
14	68	[patient name redacted] -- LBF -- Na24, 1956
14	69	[patient name redacted] -- LBF -- Na24, 1956
14	70	[patient name redacted] -- LBF -- Na24, 1957
14	71	[patient name redacted] -- LBF -- Na24, 1956
14	72	[patient name redacted], 1957
14	73	[patient name redacted] -- LBF -- Na24, 1957
14	74	[patient name redacted] -- LBF -- Na24, 1957
14	75	[patient name redacted] -- LBF -- Na24, 1956
14	76	[patient name redacted] -- LBF -- Na24, 1956
14	77	[patient name redacted] -- LBF -- Na24, 1957
14	78	NA24, 1954
14	79	Na24 -- leg blood flow studies, 1956
14	80	Na24 -- leg blood flow studies -- book 2, 1957
14	81	[patient name redacted] -- LBF -- Na24, 1957
14	82	[patient name redacted] -- LBF -- Na24, 1957
14	83	[patient name redacted] -- LBF -- Na24, 1957
14	84	[patient name redacted] -- LBF -- Na24, 1956
14	85	[patient name redacted] -- LBF -- Na24, 1956
14	86	[patient name redacted] -- LBF -- Na24, 1956
14	87	[patient name redacted] -- LBF -- Na24, 1956
14	88	[patient name redacted] -- LBF -- Na24, 1956
		Rolled paper graph readouts
134		[patient name redacted], muscular dystrophy, control and exercised, 1/24/1957 [RESTRICTED PHI]
134		[patient name redacted], 6/9/1957 [RESTRICTED PHI]
134		[patient name redacted], LBF, 5/15/1957 [RESTRICTED PHI]
134		[patient name redacted], muscular dystrophy, control and exercised, 11/1/1956 [RESTRICTED PHI]
134		[patient name redacted], myotonia atrophy, LBF with exercise, 5/16/1957 [RESTRICTED PHI]
134		[patient name redacted], 10/10/1956 [RESTRICTED PHI]
134		[patient name redacted], normal control, control priscoline, 3/7/1957 [RESTRICTED PHI]
134		[patient name redacted], LBF, muscular dystrophy with exercise, 1/20/1957 [RESTRICTED PHI]
134		[patient name redacted], leg blood flow, 10/11/1956 [RESTRICTED PHI]
134		[patient name redacted], leg blood flow, 10/31/1956 [RESTRICTED PHI]
134		[patient name redacted], leg blood flow, 2/21/1957 [RESTRICTED PHI]
134		[patient name redacted], normal, control Arlidin, 3/21/1957 [RESTRICTED PHI]
134		[patient name redacted], normal control-LBF, Na24 with Arlidin, 2/1957 [RESTRICTED PHI]
134		[patient name redacted], LBF -- normal control, with priscoline, 1, 4, leg counts, Na24, 5/14/1957 [RESTRICTED PHI]
134		[patient name redacted], normal control -- LBF with Na24, Priscoline, 50mg, I.A., 12/12/1956 [RESTRICTED PHI]
134		[patient name redacted], muscular dystrophy, 1-control, 2-exercise, 1/23/1957 [RESTRICTED PHI]
134		[patient name redacted], LBF leg counts, Na24, normal control, with Arlidin, 10mg. I.A., 10/11/1956 [RESTRICTED PHI]
134		[patient name redacted], LBF with Na24, normal control with priscoline, 50mg, I.A., 3/7/1957 [RESTRICTED PHI]
134		[patient name redacted], leg blood flow, muscular dystropy, control and exercise, 11/1/1956 [RESTRICTED PHI]
134		[patient name redacted], leg counts of Na24 at 100 [cm], 10/10/1956 [RESTRICTED PHI]
134		[patient name redacted], Arlidin, 3/21/1957 [RESTRICTED PHI]
134		[patient name redacted], myotonia dystrophica, Na24 leg blood flow with exercise, 5/16/1957 [RESTRICTED PHI]
135		[patient name redacted] (paranoid schizophrenia), leg blood flow control and exercise, 12/13/1957 [RESTRICTED PHI]
135		[patient name redacted], muscular dystrophy with exercise, Na24, leg blood flow, 2/20/1957 [RESTRICTED PHI]
135		[patient name redacted], LBF with Na24, undated [RESTRICTED PHI]
135		[patient name redacted], muscular dystrophy with exercise, Na24 leg blood flow, 1/24/1957 [RESTRICTED PHI]
135		[patient name redacted], muscular dystrophy, LBF, Na24 with exercise, 1/24/1957 [RESTRICTED PHI]
135		[patient name redacted], muscular dystrophy, LBF with Na24, exercise, 9/20/1956 [RESTRICTED PHI]
135		[patient name redacted], normal control, Arlidin, 10 mg, I.A., 6/19/1957 [RESTRICTED PHI]
135		[patient name redacted], s, LBF with Na24, Arlidin, 10 mg. I.A., 10/31/1956 [RESTRICTED PHI]
135		[patient name redacted], 12/12/1956 [RESTRICTED PHI]
135		[patient name redacted], leg blood flow, 1-control, 2-Arlidin, 10/31/1956 [RESTRICTED PHI]
135		[patient name redacted], 6/21/1956 [RESTRICTED PHI]
135		[patient name redacted], LBF, Na24 with exercise, schizo., 12/13/21956 [RESTRICTED PHI]
135		[patient name redacted], LBF with Na24, 7/11/1956 [RESTRICTED PHI]
135		[patient name redacted], myotonia dystrophica, LBF with Na24, exercise, 5/16/1957 [RESTRICTED PHI]
135		[patient name redacted], LBF with Na24, normal control, with Arlidin, 10 mg, I.A., 10/11/1956 [RESTRICTED PHI]
135		[patient name redacted], LBF with Na24, dystrophy, with exercise, 11/1/1956 [RESTRICTED PHI]
135		[patient name redacted], LBF with Na24, normal control, Arlidin, 10 mg, I.A., 3/21/1957 [RESTRICTED PHI]
135		[patient name redacted], LBF with Na24, normal control with Priscoline, 50 mg, I.A., 12/12/1956 [RESTRICTED PHI]
135		[patient name redacted], normal control, leg blood flow -- Na24, Arlidin, 10 mg, I.A., 2/21/1957 [RESTRICTED PHI]
135		[patient name redacted], LBF with Na24, Priscoline, I.A., 9/19/1956 [RESTRICTED PHI]
135		[patient name redacted], normal control, LBF with Na24, Arlidin, 10 mg, I.A., 6/19/1957 [RESTRICTED PHI]
135		[patient name redacted], LBF with Na24, normal control, Priscoline, 50 mg., I.A., 3/7/1957 [RESTRICTED PHI]
135		[patient name redacted], dystrophy, LBF with Na24 and exercise, 2/20/1957 [RESTRICTED PHI]
135		[patient name redacted], LBF with Na24 and exercise, 10/10/1956 [RESTRICTED PHI]
135		[patient name redacted], LBF with Na24, 6/6/1956 [RESTRICTED PHI]
135		[patient name redacted], 7/12/1956 [RESTRICTED PHI]
135		[patient name redacted], LBF with Na24, normal control, Priscoline, 50 mg., I.A., 8/1/1956 [RESTRICTED PHI]
135		[patient name redacted], muscular dystrophy with exercise, 1/23/1957 [RESTRICTED PHI]
135		[patient name redacted], muscular dystrophy, LBF with Na24, 1/23/1957 [RESTRICTED PHI]
		Lab notebooks
154	1-6	Books 1-6, 1952-1953 [RESTRICTED PHI]
153	1-4	Na24 clearance perfusion, book 1-2 [dogs], 1952-1953
		New born monkey (NBM) series, 1970-1979, 1983-1989
14	89	Assay of monkey blood, 1978
14	90	LCM 6, 9/30/1976
14	91	LCM-7, 10/14/1976
14	92	LCM 9, 11/18/1976
14	93	Monkey K-732-1, 1971
14	94	Monkey K739-2, 1971
14	95	Monkey lumped constant study, no. 1 [photograph], 1976
14	96	Monkey lumped constant study, no. 2, 1976
14	97	Monkey lumped constant study, no 3, 1976
14	98	Monkey lumped constant study, no 4, 1976
14	99	Monkey lumped constant study, no. 5, 1976
14	100	Monkey-control -- misc., 1985-1989
14	101	NBM-101, tarsoraphy at. 2 days, 1976-1985
14	102	NBM-2, rt. eye patched (LCGU), 11/24/1978
14	103	NBM-3, LCGU 3, 1976-1977
14	104	NBM-4 [diskette], 1983
14	105	NBM4, new born monkey, LCGU-control, 1976
14	106	NBM-5 (LCGU control), 3/15/1976
15	1	NBM-6, LCGU, 3/22/1976
15	2	NBM7 (new born monkey control), 1976
15	3	NBM-8, LCGU-30', r. eye patched, 1978
15	4	Newborn monkey, LCGU control (NBM1), 1976
15	5	PEN. SEIZ.: adult monk. controls + experimentals, 1970
15	6	PEN. SEIZ.: newborn monk. experimentals, 1970
15	7	PEN. SEIZ: newborn monkeys controls, 1970
15	8	Pen-C, 1, 1975
15	9	Series S.M.: laplace transform, 2-DG conscious monkeys, 1976
15	10	Statist. -- new born monkey, 1979
15	11	Stimulated monkey -- summary tables and graphs, undated
		PCP series, 1986-1987
15	12	PCP-1 -- 10 mg/kg, 1986
15	13	PCP -- 2 Saline 0.36, 1986
15	14	PCP -- 3 1 mg/kg, 1988
15	15	PCP -- 4 N. Saline, 1986
15	16	PCP -- 5 0.3/kg, 1986
15	17	PCP -- 6 3mg/kg, 1986
15	18	PCP -- 7 1mg/kg, 1987
15	19	PCP -- 8 0.1mg/kg, 1987
15	20	PCP -- 9 10mg/kg, 1987
15	21	PCP -- 10 N.S., 1988
15	22	PCP -- 11 3mg/kg, 1986
15	23	PCP -- 12 0.3mg/kg, 1986
15	24	PCP -- 13 1mg/kg, 1987
15	25	PCP -- 14 0.1mg/kg, 1987
15	26	PCP -- 15 3.0mg/kg, 1987
15	27	PCP -- 16 N.S., 1987
15	28	PCP -- 17 0.3mg/kg, 1986
15	29	PCP -- 18 10mg/kg, 1986
15	30	PCP -- 19 N.S., 1986
15	31	PCP -- 20 0.1mg/kg, 1987
15	32	PCP -- 21 0.3/kg, 1987
15	33	PCP 21-2, 1987
15	34	PCP -- 22 3mg/kg, 1987
15	35	PCP -- 23 10mg/kg, 1987
15	36	PCP -- 24 N.S., 1987
15	37	PCP -- 25 1mg/kg, 1986
15	38	PCP -- 26 10mg/kg, 1987
15	39	PCP 27 0.3mg/kg, 1987
15	40	PCP 28 0.1mg/kg, 1988
15	41	PCP Data, 1987
15	42	PCP Raw Data, 1986
		PT series, 1949-1950, 1979-1987
15	43	PT series -- scp*(t)/cp* -- scp*dt/T, 1949-1950
15	44	Pulse 2DG experiments -- PT series -- Ken Mori StCp*(t)dt, 1986
15	45	PT series plus experiments -- physiological conditions, 1987
15	46	Summary PT series -- stretch time etc., pulse exp. mori, 1979-1986
15	47	PT-2 -- 60 min., July 25, 1986
15	48	PT-6 -- 35 min., July 26, 1986
15	49	PT-7 -- 120 min., Aug. 4, 1986
15	50	PT-8 -- 60 min., Aug. 4, 1986
15	51	PT-9 -- 25 min., Aug. 4, 1986
15	52	PT-10 -- 90 min. exp., Aug. 5, 1986
15	53	PT-11 -- 35 min. exp., Aug. 5, 1986
15	54	PT-12 -- 45 min. exp., Aug. 5, 1986
15	55	PT-13 -- 120 min. exp., Aug. 1986
15	56	PT-14 -- 60 min., Aug. 6, 1986
15	57	PT-15 -- 25 min., Aug. 6, 1986
15	58	PT-16 -- 90 min. exp., Aug. 7, 1986
15	59	PT-17 -- 45 min. exp., Aug. 7, 1986
15	60	PT-18 -- 35 min. exp., Aug. 7, 1986
15	61	PT-20 -- 60 min. exp., Aug. 8, 1986
15	62	PT-21, Aug. 8, 1986
15	63	PT 22 -- 120 min. exp., Aug. 11, 1986
15	64	PT 23 -- 90 min. exp., Aug. 11, 1986
15	65	PT 24 -- 4-5 min. exp., Aug. 11, 1986
15	66	PT-25 -- 120 min. exp., Aug. 13, 1986
15	67	PT-26 -- 90 min. exp., Aug. 13, 1986
15	68	PT-27 -- 35 m in. exp., Aug. 13, 1986
15	69	PT-28 -- 45 min. exp., Aug. 14, 1986
15	70	PT-29 -- 25 min. exp., Aug. 14, 1986
15	71	PT-31 -- 25 min., Nov. 17, 1986
15	72	PT-32 -- 90 min., Nov. 18, 1986
15	73	PT-33 -- 25 min., Nov. 18, 1986
15	74	PT-34- 45 min. exp., Nov. 24, 1986
15	75	PT-35 -- 35 min. exp., Nov. 24, 1986
15	76	PT-36 -- 35 min., Nov. 24, 1986
15	77	PT-37 -- 45 min., Nov. 25, 1986
15	78	PT-38 -- 35 min., Nov. 25, 1986
15	79	PT-39 -- 45 min. exp., Nov. 26, 1986
15	80	PT-40 -- 25 min. exp., Nov. 26, 1986
15	81	PT-41 -- 25 min. exp., Nov. 26, 1986
15	82	PT-42 -- 60 min. exp., Nov. 28, 1986
15	83	PT-43 -- 35 min. exp., Nov. 28, 1986
15	84	PT-44 -- 45 min. exp., Nov. 28, 1986
15	85	PT series -- parameters with new three rate constants -- K1*=0.232, K2*=0.240, K3*=0.061, 1985-1986
		PX series, 1978
15	86	PX-0 (.42 mg/kg), 5/3/1978
15	87	PX-01 (.42 mg/kg), 8/21/1978
15	88	PX-02 (.42 mg/kg), 8/21/1978
15	89	PX-1 (21 mg/kg, 8.6 mg pulse), 2/8/1978
15	90	PX-2 (7.8 mg pulse), 2/29/1978
15	91	PX-3 (8.5 mg pulse), 2/29/1978
15	92	PX-4 (21 mg/kg, 8.2 mg pulse), 3/15/1978
16	1	PX-5 (4.2 mg/kg), 3/30/1978
16	2	PX-6 (4.2 mg/kg), 3/30/1978
16	3	PX-7 (4.2 mg/kg), 4/5/1978
16	4	PX-8 (4.2 mg/kg), 4/12/1978
16	5	PX-9 (42 mg/kg), 4/12/1978
16	6	Px-10, 4/19/1978
16	7	Px-11, 4/19/1978
16	8	PX-12 (4.2 mg/kg), 4/27/1978
16	9	PX-13 (4.2 mg/kg), 5/9/1978
16	10	PX-14 (42 mg/kg), 5/9/1978
16	11	PX-15 (4.2 mg/kg), 8/21/1978
16	12	PX-16 (21 mg/kg), 8/21/1978
16	13	PX-17 (42 mg/kg), 8/25/1978
16	14	PX-18 (9 mg/kg), 12/10/1978
16	15	PX-19 (9 mg/kg), 12/10/1978
16	16	PX-20 (9 mg/kg), 12/11/1978
16	17	PX-21 (9 mg/kg), 12/22/1978
16	18	PX-22 (9 mg/kg), 12/13/1978
		SM series, 1973-1985
16	19	SM-1, B-45'-320 ul -- rt. eye covered and wurtz, 1975
16	20	Series SM-2: unilateral patching, 1973
16	21	SM-2A, B'-45'-100 uc, both eyes opened, 1973-1978
16	22	SM-3, P-45'-250 uc. (rt. eye patched), 1973-1975
16	23	SM-3A, visual: rt. eye removed, P-45'-250 uc, 1973-1975
16	24	SM-4A, both eyes opened and wurtz pattern -- P-45'-300 uc, 1973-1975
16	25	Series SM-5: both eyes patched, 1975
16	26	SM-6, 45'-300 mc -- both eyes patched, 1974-1975
16	27	Series SM-7: eyes intact + stimulation, 1974
16	28	SM-8A, 1974-1977
16	29	Series SM-9A: eyes intact + stimulation, 1975-1977
16	30	SM-10, both eyes intact and wurtz pattern, 1974-1975
16	31	SM-11, 1978
16	32	SM-11, both eyes intact and wurtz, pattern, 1974-1977
16	33	Series SM-12: eyes intact + stimulation, 1974-1977
16	34	SM-13, left eye removed and wurtz, 1974
16	35	SM-14, rt. eye removed and ambient light, 5/1/1975
16	36	Series SM-15: unilateral enucleation, 1975
16	37	Series SM-16: unilateral enucleation, 1975
16	38	SM-17, left eye patched and wurtz, 8/7/1975
16	39	Series SM-18: unilateral enucleation, undated
16	40	SM-19, left eye patched and wurtz, 11/6/1975
16	41	SM-20, left eye patched and wurtz, 11/20/1975
16	42	SM-21, rt. eye patched and wurtz [photograph], 12/23/1975
16	43	SM-22, left eye removed and wurtz, 12/23/1975
16	44	SM-23, both eyes open, 1/23/1976
16	45	SM-24, both eyes patched, 2/5/1976
16	46	SM-25, 2/19 -- rt. eye patched and wurtz, 2/19/1976
16	47	SM-26, 3/19 -- rt. eye patched and wurtz, 3/19/1976
16	48	SM-27, 5/28 -- both eyes opened and wurtz, 5/28/1976
16	49	SM-28, 8/2/1976
16	50	SM-29, 11/4/1976
16	51	SM-30, 12/9/1976
17	1	SM-31, 1976-1985
17	2	SM-32, 1/18/1977
17	3	SM33 and SM24, densitometry, undated
17	4	SM-33, both eyes occluded, 8/4/1977
17	5	SSM-1/SSM-3, undated
17	6	SSM-2, 1979
17	7	SSM-2 [diskette], 4/7/1977
17	8	SSM-4 (rt. optic tract sectioned), 1977
17	9	SSM-4 [8 computer disk]", 1979
		SR series, 1973-1974
17	10	Series SR-1: visual alterations, 1973
17	11	Series SR-1A: visual alterations, 1973
17	12	Series SR-2: visual alterations, 1973
17	13	Series SR-2A: visual alterations, 1973
17	14	Series SR-3: visual alterations, 1973
17	15	Series SR-3A: visual alterations, 1973
17	16	SR-3B (l. eye remove), 1973
17	17	SR-4-I (r-eye remove), 1973
17	18	SR-4-II (l-eye remove), 1973
17	19	S.R.-5, (left eye patched, TOT -- darkness, I.P.S.), 1973
17	20	Series SSR: sciatic nerve stimulation, 1974
		Thyroxine series, 1954-1975
17	21	Reprints -- thyroxine, 1956
17	22	Summaries of thyroxine mitochondrial factor studies, 1964-1965
17	23	Summaries thyroxine effects on pyridine nucleotides, 1975
17	24	T4 effect on mitochondrial NAD+, 1970
17	25	Thyroxine -- illustrations [photographs, negatives], undated
17	26	Thyroxine -- protein synthesis, 1955-1965
17	27	Thyroxine -- protein synthesis in vivo, 1963-1964
136	8-9	Thyroxine -- Protein Synthesis -- Index, undated
17	28	Thyroxine -- uptake by brain, 1954-1955
17	29	Thyroxine analogues [photographs, negatives], 1963
17	30	Thyroxine effects on NAD+, 1974
17	31	Thyroxine effects on pyridine nucleotides -- amino-chance scans [folder 1 of 3], 1974-1975
17	32	Thyroxine effects on pyridine nucleotides -- amino-chance scans [folder 2 of 3], 1974-1975
17	33	Thyroxine effects on pyridine nucleotides -- amino-chance scans [folder 3 of 3], 1974-1975
17	34	Thyroxine effects on pyridine nucleotides, 1974
17	35	Thyroxine experiments, 1964
18	1	Thyroxine experiments -- book 2, 1957-1958
18	2	Thyroxine experiments -- book 3, 1958
18	3	Thyroxine factor [negatives], undated
18	4	Thyroxine iodine studies, 1954-1955
18	5	Thyroxine mechanism -- tables and illus. [photographs, negatives], undated
136	10	Thyroxine-Mitochondrial Factor -- Index [includes slides], undated
18	6	Thyroxine project -- charts and slides [photographs, negatives], undated
18	7	Thyroxine project -- charts and slides [photographs, negatives], undated
18	8	Thyroxine solutions, 1959-1964
18	9	Thyroxine solutions II, 1965-1972
18	10-12	Thyroxine-mitochondrial factor -- preparations and properties -- book 1, 1966-1968
		Whisker barrel (WB) series, 1991-1993
18	13	WB i.v. study, statistics, 1992
18	14	01 whisker barrel series: control, 1991
18	15	WB-02 experiment NMA 30 mg/kg, 1991
18	16	WB-03 control, 1991
18	17	WB-04, control, 1991
18	18	WB-05, experiment NMA 30 mg/kg, 1991
18	19	WB-06, exp. normal saline 1.1 ml, 1991
18	20	WB-07, exp. NMA 30 mg/kg, 1991
18	21	WB-08, exp. NMA 30 mg/kg, 1991-1992
18	22	WB-09, control, 1991
18	23	WB-09, control, 1991
18	24	WB-11, exp. NMA 30 mg/kg, 1991
18	25	WB-12, NMA 100 mg/kg, 1991
18	26	WB-13, NMA 100 mg/kg, 1991
18	27	WB-14, NMA 100 mg/kg, 1991
18	28	WB-15, NMA 100 mg/kg i.v., 1991
18	29	WB-16, control (saline + no stimulation), 1991
18	30	WB-17, NMA 30 mg/kg i.v., 1991-1992
18	31	WB-18, control, 1991-1992
18	32	WB-19, saline i.v. + no stimulation, 1991
18	33	WB-20, control, 1991
18	34	WB-21, control, 1991-1992
18	35	WB-22, methyl ester, 1992
18	36	WB-22, methyl ester 30 mg/kg i.v., 1992
18	37	WB-24, control, 1992
18	38	WB-25, NAME, 1992
18	39	WB-26, control (saline i.v. and no stimulation), 1992
18	40	WB-27, NAME, 1992
18	41	WB-28, control, 1992
18	42	WB-29, control, 1992
18	43	WB-30, nitro-L-arginine methylester, 1992
18	44	WB-31, control, 1992
18	45	WB-32, nitro-L-arginine methylester, 1992
18	46	WB-33, NAME, 1992
18	47	WB-34, control, 1992
18	48	WB-35, nitro-L-arginine methylester, 1992
18	49	WB-36, nitro, fast infusion, 1992
18	50	WB-37, control, 1992
18	51	WB-38, nitro-L-arginine M.E., 600 ug/rat, 1992
18	52	WB-39, control (DIR), 1992
18	53	WB-40, nitro (direct), 600 ug/rat, 1992
18	54	WB-41, control (direct), 1992
18	55	WB-42, nitro-L-arginine (direct), 1992
18	56	WB-43, nitro-L-arginine, 600 ug/rat, 1992
18	57	WB-44, control, 1992
18	58	WB-45, nitro-L-arginine, 600 ug/rat, 1992
18	59	WB-46, nitro-L-arginine, 600 ug/rat, 1992
18	60	WB-47, control, 1992
18	61	WB-48, control, 1992
18	62	WB-49, nitro-L-arginine, 600 ug/rat, 1992
18	63	WB-50, control, 1992
18	64	WB-51, nitro-L-arginine, 600 ug/rat, 1992
18	65	WB-52and53, 3H-nitro-L-arginine and intracisternal infusion, 1993
18	66	WB-54, chronic and NAME, 1993
18	67	WB-55, chronic i.p. and NAME, 1993
18	68	WB-56, chronic ad of NAME, 1993
18	69	WB-57, chronic i.p., 1993
18	70	WB-58, chronic i.p., 1993
18	71	WB-59, chronic i.p., 1993
18	72	WB-60, L-NAME chronic i.p., 1993
18	73	WB-61, chronic i.p., 1993
18	74	WB-62, chronic i.p., 1993
18	75	WB-63, saline chronic i.p., 1993
18	76	WB-64, saline chronic i.p., 1993
18	77	WB-65, saline chronic i.p., 1993
18	78	WB-66, saline chronic i.p., 1993
19	1	WB-cisternal infusion, 1992
19	2	WBDG -- DG parity check, 1992
19	3	WBDG-1, 1992
19	4	WBDG-2, 1991-1992
19	5	WBDG-3, 1991-1992
19	6	WBDG-4, 1992
19	7	WBDG-5, 1992
19	8	WBDG-6, 1992
19	9	WBDG-7, 1992
19	10	WBDG-8, 1992-1993
		YOH series, 1978
19	11	YOH-1 (.25 mg/kg/min.), 4/5/1978
19	12	YOH-3 (.25 mg/kg/min.), 7/10/1978
19	13	YOH-4 (.25 mg/kg/min.), 7/10/1978
19	14	YOH-5 (.1 mg/kg/min.), 7/11/1978
19	15	YOH-6 (.25 mg/kg/min.), 7/11/1978
19	16	YOH-7 (.1 mg/kg/min.), 7/11/1978
19	17	YOH-10 (.25 mg/kg/min.), 8/19/1978
19	18	YOH-11 (.1 mg/kg/min.), 8/30/1978
19	19	YOH-12 (.25 mg/kg/min.), 9/8/1978
19	20	YOH-13 (.25 mg/kg/min.), 9/8/1978
19	21	YOH-14 (.25 mg/kg/min.), 9/8/1978
19	22	YOH-15 (.025 mg/kg/min.), 9/18/1978
19	23	YOH-16 (.025 mg/kg/min.), 9/18/1978
19	24	YOH-17 (.1 mg/kg/min.), 12/14/1978
19	25	YOH-18 (.1 mg/kg/min.), 12/14/1978
19	26	YOH-19 (.05 mg/kg/min.), 12/15/1978
19	27	YOH-20 (.05 mg/kg/min.), 12/15/1978
19	28	YOH-21 (.05 mg/kg/min.), 12/18/1978
19	29	YOH-22 (.05 mg/kg/min.), 12/18/1978
19	30	YOH-23 (.05 mg/kg/min.), 12/19/1978
19	31	YOH-24 (.0025 mg/kg/min.), 12/20/1978
19	32	YOH-25 (.025 mg/kg/min.), 12/20/1978
19	33	YOH-26 (.025 mg/kg/min.), 12/20/1978
19	34	YOH-27 (.0025 mg/kg/min.), 12/21/1978
19	35	YOH-28 (.0025 mg/kg/min.), 12/21/1978
19	36	YOH-29 (.0025 mg/kg/min.), 12/21/1978
		Other experiments, 1952-2003
152	24	Laboratorie de Biochemie Generale at et Comparee de France, Paris -- experiment binder, 1968-1969
19	37	1. aging -- CBF -- Normal, 1955-1957
19	38	2. aging -- CBF -- hypertension, 1956
19	39	3. aging -- CBF -- arteriosclerosis, 1956-1957
19	40	4. aging -- CBF -- chronic brain syndrome, 1957-1958
19	41	B. aging -- patient material, 1957-1959
19	42	C. Aging -- Statistics, 1958-1959
19	43	C. Aging -- Statistics, 1959
19	44	D Aging -- Inter Correlations, 1959-1960
19	45	E Aging -- research data, 1959-1960
20	1	ANES series, 1993
20	2	ANES 1-5, Jan. 5-11, 1993
20	3	ANES 6-10, Jan. 12-25,1993
20	4	ANES 11-15, Feb. 1-9, 1993
20	5	ANES 16-20, Feb. 16-23, 1993
20	6	ANES 21-25, March 21-31, 1993
20	7	ANES 26-30, March 9-22, 1993
20	8	ANES 31-34, March 23-28, 1993
20	9	ANES, 1992
20	10-11	Arterial curves -- O2 -- C02 series, 1956
20	12-13	Arterial curves -- SCL series [photographs], 1956
20	14	CE-1: lumped constant rat, 5%, CO2 inhal, 1974
20	15	CE-2: lumped constant rat, 5% CO2 inhal., undated
20	16	CE-3: lumped constant rat, 5% CO2 inhal., 1975
20	17	CE-4: lumped constant rat, 5% CO2 inhal., 1975
20	18	CK1, 60 min. normal control, 6/15/1978
20	19	CK2, 60 min., 6/15/1978
20	20	CS-23, 7/10/1978
20	21	CS-24, 8/21/1978
20	22	CS-26, 12/13/1978
20	23	CS-27, 12/14/1978
20	24	G5 Ur W5 V4 original rate constants, undated
20	25	Parameters (V4 V4 G6 W5) pulse experiments -- new 3 rate constants, 1985
20	26	HYP1 (10%), 1/15/1976
20	27	HYP2 (10%), 1/15/1976
20	28	HYP-3 (7.5% O2), 1/21/1976
20	29	HYP-4 (7.5% O2), 1/21/1976
20	30	Hypoxia 10% O2 behavior: observation, 1976
20	31	LCBF summary, undated
20	32	LCBF summary for misc. data, undated
20	33	Sheet for LCBF, undated
20	34	1 washout constant exp., flow rate: 0.8 ml/min., 1991
20	35	2 washout constant exp., flow rate: 1.0 ml/min., 1991
20	36	03 washout constant exp., flow rate: 1.2 ml/min., 1991
20	37	04 washout constant exp., flow rate: 0.6 ml/min., 1991
20	38	05 washout constant exp., flow rate: 1.4 ml/min., 1991
20	39	06 washout constant exp., flow rate: 1.6 ml/min., 1991
20	40	Washout correction for LCBF equation, undated
20	41-42	Wynn project -- alleged non-mitochondrial thyroxine stimulation of protein synthesis -- Nov. 9, 1970
20	43	2 Deoxyglucose Studies (Rat, Cat), 1973-1983
20	44	2.5 min., undated
20	45	5.0 min., undated
20	46	10 min., undated
20	47	15 min., undated
20	48	30 min., undated
20	49	45 min., undated
20	50	60 min., undated
20	51	90 min., undated
20	52	120 min., undated
20	53	14C Toluen internal std. -- lot 0060283A, 1986
20	54	14c-warfarin, 1993
20	55	Abrams -- lumped constant data, 1985
136	11	Absorption Spectra, undated
20	56	Additional structure morphine, undated
20	57	Alfred Benzon symposium, 1990
20	58	Amanda, 12/5/1979
20	59	Amersham standard calibration, 1978
20	60	Analytical ultracentrifuge records [photographs], 1966
20	61	Anesthesia record, undated
21	1	Animal phosphate [photographs], 1978
21	2	AP vs. IAP rat summary, undated
21	3	Arithmetic mean value of gray structures (pulse experiments), 1979
21	4	Arterial blood studies (Tbl 1) (from Reivitch, et. al.) [slides], 1977
21	5	Astroglial exp. -- amino acid analysis key, 1995
21	6	Astroglial exp. -- Dr. Kaufman's cell extract samples, 1995
21	7	Astroglial exp. -- intracellular A.A., 1995
21	8	Atlas -- 1, 1980
21	9	Amino-acid-analyzen, 1992
21	10	A. V. blood curves -- desaturation curves studies, 1952-1956
21	11	Banzo (sleep control), 1980
21	12	Basil, 6/13/1979
21	13	Beckman polygraph calibration, undated
21	14	Blank sheets for experiments, undated
21	15	Crop, 6/25/1979
21	16	Brain development, undated
21	17	Bonzo, film 21, 1985
21	18	Brain -- (Gelber) photos and negatives [photographs, negatives], 1967
21	19	Calibration of plastic standards, 1969-1975
21	20	Calibration of standards, undated
21	21	Calibration standards using the 10 and "new low" standards"", 1986
21	22	Catheter -- calibration exp., 1991-1992
21	23	Catheter smear collection, undated
21	24	Caveness study materials [photographs], undated
21	25	CCK -- vagotomized, 1980
21	26	Chico, 1980-1984
21	27	Chr. Li-1, 5/27/1980
136	12	Chromatogram Records, 1960
21	28	Chronic -- nitro i.p., 1993
21	29-30	Chronic i.p. of L-NAME series vol. 1-2, 1993
21	31	Clinical trials of barbiturates in rats, 1972
21	32	Collaboration -- Bill Eckelman and Juntendo Univ., 1999
21	33	Collaboration -- Dr. David M. Cohen, 2000-2003
21	34	Collaboration -- Dr. Rolf Gruetter -- Univ. of Minnesota, 1999-2001
21	35	Collaboration -- SuperGen, 1999-2000
21	36	Dee, film 8-35, 1978
21	37	Dee, film no. 7-35, 1979
21	38-39	Densitometric calibration curves, 1953-1955
21	40	Densitometry 1, 1953-1954
21	41	Densitometry 2, 1954
22	1	Deoxyglucose review, 1980-1981
22	2	Directories -- disk and tape, 1985
22	3	Discarded animals, 1972
22	4	Dreamless, film 17, undated
22	5	Dreamless, 1980
22	6	ECF mixed culture (counting data), 1995
22	7	ECG, EOG and EMG (from Reivitch, et. Al.) [Slides], 1985
22	8	Effects of barbiturates on blood gases, undated
22	9	Effects of epinephrine on blood glucose, 1958-1959
136	13	Effects of Thiopental Anesthesia on Local Cerebral Glucose Utilization in the Albino Rat, undated
22	10	Equilibrium, undated
22	11	ER-M, C-31'-236 uc., 1973-1974
22	12	Exp. CC1, 1980
22	13	Exp. CC2, 1980
22	14	Exp. CC5, 1980
22	15	Exp. CR2, 1980
22	16	Exp. CR3, 1980
22	17	Exp. CR4, 1980
22	18	Exp. CR6, 1980
22	19	Exp. CR7, 1980
22	20	Experiment 6: raw data -- nucleotide separation by high voltage electrophoresis, 1970
22	21-22	Factor preparation and properties -- book 2, 1968-1974
22	23	Factor TLC scans, 1969
22	24	Failed experiment, Aug. 22, 1991
136	14	Fasting and Brain Metabolism, 1969-1973
136	15	G. Fitzgerald Experiments, 1971
22	25	G5 U4 with new 3 rate constants -- Ki*=.232, K2*=.240, K3*=0.61, 1985
22	26	GEE -- experiment work sheep, 1978-1979
22	27	GEE file no. 7-33, 1979-1980
22	28	Glucose deter.: Beckman vs. Gilford, 1975
22	29	Glucose deter.: with glass vs. Eppendorf pipets, 1975
22	30	Glucose determination (spectrophotometer), undated
22	31	Glucose determination: glucose oxidase method, undated
22	32	Glucose determination: miscellaneous, 1973-1975
22	33	GU-BMF (multi-film program), undated
22	34	Guide to reading auto radiographs, undated
22	35	Hemoglobinometry, 1979
22	36	HG misc., 1980
22	37	High-std-1, 14c meth. Glucose, 1978
22	38	History: rat thyroidectomies, 1960-1966
22	39	Hydroxybuty rate assay, 1969
22	40	Hyperinsulinemia experiments, 1980
22	41	Info. on micropipettes and pumps, 1973
22	42	Insulin hypoglycemia (50 uci/animal), undated
22	43	Internal standard, 1985
22	44	L.S. brain -- I, 1977
22	45	Laplace transform -- technical info., 1975
22	46	Liquid scintillation media, 1974
22	47	List of research projects planned, undated
22	48	Low standard I graph, 1977
22	49	LSD-DG series, 1975-1976
22	50	M. Shionohara -- summarized date, 1979
22	51	Manuscript -- Dr. Sokoloff [photographs], undated
22	52	Marburg slides, undated
22	53	Mean weighted average (GU) -- square exp. (GU was calculated with weighted average of tissue conce.), 1979
22	54	Mean weighted average of GU (GU was directly calculated by image processor), undated
22	55	Metabolic maturation of the brain in relation to asphyxia neonatorum, 1963-1964
22	56	Milt, 6/14/1979
22	57	Milt, film no. 1-32, 1979-1982
22	58	Misc. papers, 1979-1980
22	59	Miscellaneous statistical analyses, 1960
22	60	Mixed and astroglial culture, 1995
22	61	Morphine summary, undated
22	62	MTZ-1, 1/1/1975
22	63	MTZ-2, 1/2/1975
22	64	N.E.N. standard calibration, 1978-1979
23	1	NH3 -- 1-3, HF -- 1-2, GD -- 1-3, DLX, DX 1-4 Rats [X- Rays], 1977
23	2	N.O.S. assay, 1992-1993
23	3	Nitro i.p. -- enzyme assay, 1993
23	4	No synthase assay, 1992-1993
23	5	NOD, 3/18/1980
23	6	Nodoz [photographs], 4/8/1980
23	7	Nodoz, film 6, 1980
23	8	NOS activity after nitroarginine intracisternal infusion, 1993
23	9	Nose, 3/22/1979
23	10	OD vs. con. x time, undated
23	11	Olf. Bulb, undated
23	12	Original 3-rate constants, 1986
23	13	Parameters (pulse experiments ) 5 rate constants (K4*=0.0014), 1986
23	14	Parameters (pulse experiments) -- 5 rate constants (K4*=0.002), 1986
23	15	Parameters (square exp.) 5 rate constants, 1986
23	16	Parsley, 7/10/1980
136	16	Peroxidase Kinetics -- Model #1, undated
136	17	Peroxidase Kinetics -- Model #2, undated
136	18	Peroxidase Kinetics -- Model #3, undated
23	17	Phosphate, 1979
23	18	Phosphate, 1978
23	19	Physiological conditions' summary -- pulse exp., undated
23	20	Plasma curves, undated
23	21	Poly. fitting -- plastic standards, 1973
23	22	Posh, 8/6/1980
23	23	Pulse experiments parameters -- 5 rate constants (K4*=0.001), 1986
23	24	Pump schedule sheet, undated
23	25	Puromycin -- originals negatives [negatives], undated
23	26	Psychological vs. Physiological, 1961
23	27	Radiochemical specifications, 1967-1974
23	28	Rat DX-4, 1971
23	29	Rate constant experiments, 1970-1992
23	30	Red-outline drawings, undated
23	31	REM4, awake cont. cat, 1976
23	32	REM5, 1976
23	33	Reproduce Iadecola's experiment, 1992
48	28	Research medicine [experiment proposal], 1992
23	34	Reza, 9/10/1979
23	35	Ribosomal protein -- orig. photos and neg. [photographs, negatives], undated
23	36	Roche system -- originals and photographs [negatives], undated
23	37	Rocky, undated
23	38	Rocky, 10/26/1978
23	39	Rocky, film no. 1-32, 1979
23	40	Sakurada abstract -- effects of immobilization, 1977
23	41	Salicylates -- illus. and negatives [negatives], undated
136	19	Separation of AMP, ADP, and ATP Using Electrophorisis, 1970-1971
23	42	Series AB: laplace transform, 2 DG. rats: BARB. ANES, 1975
23	43	Series AUD-111: auditory alterations, 1973
23	44	Series AUD-2: auditory alterations, 1974
23	45	Series AUD-3: auditory alterations, 1974
23	46	Series AUD-4: auditory alterations, 1974
23	47	Series CB: laplace transform, 2DG. rats: 5% CO2, 1975
23	48	Series NH: ammonium acetate -- 10 m. moles/kg i.p., 1972
23	49	Series normal: normal values in rats, 1971
23	50	Series R-ER-1 to R-ER-7 -- trial at square wave rats -- conscious, 1974
23	51	Series WB: laplace transform, 2DG rats: conscious, 1975
23	52	Shaky [photograph], 12/20/1979
23	53	Short counts on Beckman L.S5801, 1985
23	54	Sierra, 1980-1984
23	55	Sleep -- spinal cord, undated
24	1	Sleep (end Kennedy files), 1980
24	2	Sleep 1 (fang), 2/13/1980
24	3	Sleep study, 1981-1990
24	4	Snooz, 1/5/1980
24	5	Sparky -- myelinated [photographs], 1983
24	6	Spot -- sleeping, 2/12/1981
24	7	Standard calibration, 1979
24	8	Standard strip calibration from G. Dauth, neurosci., Univ. of Mich., Feb. 9, 1980
24	9	Standards, 1979-1983
24	10	Sugar, 1979
24	11	Sugar, film no. 1-28, 1979
24	12	Summarized data for computer analysis, undated
24	13	Summary of parameters (pulse exp.) (square exp.), undated
24	14	Summary of parameters (square exp), undated
24	15	Summary sheets, 1968-1974
24	16-20	Summary tables and graphs, undated
24	21	T3 Be Vwa time course data for Dr. Greenhouse, undated
24	22	Tent rat training record, 1993
24	23	TSC-1, Nov. 10, 1975
24	24	TSC-2, Dec. 1, 1975
24	25	TSC-3, Dec. 2, 1975
24	26	TSC-4, Dec. 4, 1975
136	20	University of Pennsylvania [Research Notes], 1950-1953
136	21	[Unidentified Research Notes], [circa 1950s]
24	27	Values of rate constants in the normal conscious albino rat, undated
24	28	Visual alteration: enucleation, 1973
24	29	Weighted average concentration -- (pulse experiments) Dr. Shinohara's data, 1986
24	30	Whole blood samples, undated
24	31	Windy, 1978
24	32	Windy [photograph], 1978-1979
24	33	Windy, film no. 7-33, 1978
24	34	Winx, 1985
24	35	Winx (sleep control), 1980
24	36	Winx, film 16, 1987
		Research Notebooks, 1952-2002 [subseries]:
24	37	A -- 9 5 HTT Mice, 2002
24	38	Aldose reductase, 1989
25	1	Alison's notebook -- Cathy, 1989
25	2	Alison's notebook -- C-fox S-S rats, 1989-1990
25	3	Alison's notebook -- hematology plates (property of J. D. Brown HMI), 1956
25	4	Alison's notebook -- HRP ganglion and stimulation [photograph], 1982
25	5	Alison's notebook -- hypothyroid rats, 1979-1980
25	6	Alison's notebook -- ICSS surgery, 1981-1989
25	7-8	Alison's notebook -- ICSS testing book, 1984-1987
25	9	Alison's notebook -- Lida's baby rats, 1982
25	10	Alison's notebook -- LSU series, autoradiography and histology, 1986
25	11	Alison's notebook -- MFB rats, 1989
25	12	Alison's notebook -- new protocol for temp. experiments, undated
25	13	Alison's notebook -- papers/protocols, 1989-1990
25	14	Alison's notebook -- rats, 1988
25	15	Alison's notebook -- temp. experiments, 1987
25	16	Alison's notebook -- water rats, undated
25	17	Animal record book, 1958-1960
25	18	Annual report -- laboratory of clinical science, 1962-1963
25	19	Assays, enzymes and preparations, 1958-1966
25	20	Autoradiography, 1976-1977
25	21	Autoradiography, 1979
26	1	Autoradiography, 1994-1996
26	2	Autoradiography book I and book II, 1978
26	3	Bay K 8644, 2000
26	4	Blood oxygen book I, 1954-1957
26	5	Bilateral CBF St. Elizabeth's, 1962-1964
26	6	Brain G-6pase rate constants K4K5, 1990-1993
26	7	CY Bay K continuous Infusion (wisker 2D G), 2001
26	8	Dr. Kennedy and Alison -- perfused 2 DG animals, 1979
26	9	Durell, 1954
26	10	Elaine Kaufman notebook: book 1 -- enzyme purification, 1986-1987
26	11	Elaine Kaufman notebook: book 2 -- enzyme purification, 1987-1988
26	12	E. Kaufman notebook: GLIA -- I, 1986-1988
26	13	E. Kaufman notebook: GHB dehydrogenase II, 1982
26	14	GLIA 4, 1993-1994
26	15	E. Kaufman notebook: GLIA -- book 5, 1995
26	16	E. Kaufman notebook: GLIA -- neurons, book 6, 1996-1997
27	1	Elaine Kaufman notebook: GLIA -- neurons (book -- 7), 1998-1999
27	2	E. Kaufman Notebook: Book IX, 1971-1972
27	3	E. Kaufman notebook: survey book, 1972-1981
27	4	Elaine Kaufman notebook -- GHB enzyme in GLIA and neurons, 1988
27	5	Elaine Kaufman notebook: GHB, 1984-1985
27	6	Elaine Kaufman notebook: GHB clinical studies, 1984-1985
27	7	Elaine Kaufman notebook: GHB-C-AMP, book I, 1991-1992
27	8	Elaine Kaufman notebook: GHB degradation II, 1985-1986
27	9	Elaine Kaufman notebook: GHB degradation III, 1986-1989
27	10	Example of experimental protocols -- factor method -- Patricia A. Roberts, 1966-1968
27	11	GHB-C-AMP, book II, 1992-1994
27	12	GB- 19 -GB22 -- HLI -- HL25 -- GB25 -- GB30, 1999
27	13	GB31 -- 52 -- GM1 -- 20, 2000
27	14	GHB biosynth. -- B40, 1986-1993
27	15	GHB-Dehydrogenase preparation, 1979-1980
28	1	Glucose, 1957-1959
28	2	Glucose determination, 1955-1957
28	3	Haloperidol (HX) -- Glibenclamide (GB), 1999
28	4	IAP book I, undated
28	5	Instruments, 1952-1957
28	6	J.D., 1952-1955
28	7-17	Jane Pietrosewicz -- autoradiography books, 1980-1992
29	1-3	Jane Pietrosewicz -- autoradiography books, 1993, 1996-2002
29	4	K- Channel Opener, undated
29	5	L. Libow data, 1961
29	6	Large scale assay, 1967-1969
29	7	Micro analysis of Iodine in Tissues, 1955
29	8	Miscellaneous experiments, 1959-1968
29	9	Miscellaneous preparation, assays, 1969
29	10	Miscellaneous Warburg experiments, 1956-1958
29	11	ND 28-31 CK 15-, 2002
29	12	Nifedipine, 2001
29	13	Nimodipine (ND) -- Ibenotoxin (CK), 2001
29	14	Nitrogen determination -- book I, 1958-1962
29	15	Nitrogen determination -- book 2, 1962-1967
29	16	Nitrogen determination -- book III, 1967
29	17	Note book -- Jane Jehle, 1964-1975
29	18	Organic synthesis -- book I, 1959
29	19	Oxidative phosphorylation -- book 2, 1958
29	20	Personal solutions 1, 1970-1972
30	1	PH., 1956-1958
30	2	Phosphate determinations -- book 1, 1962-1969
30	3	Phosphate determinations -- book II, 1969
30	4	Preparations of ribosomes -- book 1, 1963-1966
30	5	Preparations of SRNA amino acid -- book IA, B, and C, 1961
30	6	Preparations of SRNA amino acids -- book II-C, 1961-1964
30	7	Preparations of SRNA amino acids -- book III-C, 1965
30	8	Protein determinations -- Biuret method, 1971
30	9	Protein determinations -- Kjeldahl method, 1963-1964
30	10	Protein determinations: Lowry method -- book 1, 1963-1967
30	11	Protein determinations: Lowry method -- book 2, 1967-1971
30	12	Protein determinations: Lowry method -- book 3, 1972
30	13	Pyruvate carobxylase in brain -- GLIA II, 1988-1989
30	14	R. Neill, 1973
30	15-20	Research notebook -- book 1-6, 1970-1972
31	1-14	Research notebook -- book 4-17, 1958-1963
32	1	Research notebook -- book 18, 1963
32	2	Research notebook -- book 19F, 1964-1965
32	3	Research notebook -- book 19M, 1964-1966
32	4-9	Research notebook -- book 20F-25F, 1965-1969
32	10	Research notebook -- book 1BR, 1960-1970
32	11-14	Research notebook -- book 2T-5T, 1964-1966
33	1-7	Research notebook -- book 6T-12T, 1966-1967
33	8-12	Research notebook -- book 7-11, 1972-1973
33	13	Research notebook -- book IIA, 1961
33	14	Research notebook -- book IIB, 1961-1962
33	15	Research notebook -- book IIIA, 1962-1963
33	16	Research notebook -- radioactive phosphate and adensive nucleotide experiment, 1960-1965
33	17	Research notebook -- salicylate effects on amino acid incorporation (SEOAAI) -- book 1, 1966
33	18-22	Research notebook (SEOAAI) -- book 2-6, 1966-1967
33	23	RLK solutions I, 1964-1966
34	1-2	RNA determinations -- book 1 and 2, 1963-1967
34	3	Salicylate, 1966
34	4	Section on cerebral metabolism, 1954-1958
34	5	Section on cerebral metabolism -- sample wts. for radioactive assay PH, 1956-1958
34	6	Section on cerebral metabolism -- 26F, 1970
34	7	Section on cerebral metabolism -- 27F, 1970-1974
34	8	Section on cerebral metabolism -- book 1, 1958-1959
34	9	Section on cerebral metabolism -- EP + Nor EP -- book 1, undated
34	10	Sleep, 1966
153	7	[Sleep] Dr. Kety, 1950-1951 [RESTRICTED PHI]
153	8	[Sleep] Mental activity #2, 1952 [RESTRICTED PHI]
34	11-12	Solutions -- B. A. Jant Franke, 1966-1973
34	13	Solutions -- B38, 1985-1994
34	14-16	Solutions -- book I, 1956-1965
34	17	Solutions IV, 1965-1966
34	18	Solutions VI, 1973-1976
34	19	Solutions -- local protein synthesis, 1982
34	20	Solutions, T. Nelson, 1975-1984
35	1	Specifications and criteria for biochemical compounds, 1960
35	2	Spectophotometry, 1954-1958
35	3	Spectrophotometry 2 -- 02 saturation blood, 1957-1958
35	4-5	Sydell Gelber, 1959-1960
35	6	Synthesis of monoiodohistidine, 1968
35	7	The effect of thyroid hormone on purified kinase enzymes -- book I, 1967
35	8	Thyroid Mice Study, 2001
35	9	Thyroid solutions, 1966-1967
153	9	Thyroid, 1948-1949 [RESTRICTED PHI]
153	10	Thyroid (concluded), 1951-1952 [RESTRICTED PHI]
35	10	Van Slyke analyses, 1955-1956
35	11	Van Slyke manometer -- book I, 1954-1956
35	12	Van Slyke manometer -- book III, 1955-1956
35	13	Van Slyke -- Gladys Ellis -- book IV, 1956-1958
35	14	Van Slyke data -- book V, 1956-1958
35	15	Van Slyke -- book VI, 1958
35	16	Warburg calibration -- standard solutions, 1957-1959
35	17	Warburg experiments -- book 1, 1955-1957
		Research Data PET Scans, 1953-2002, undated [subseries]:
		Numbered, 1981, undated
50	1	1 autoradiograph with standard [photographs, negative], undated
50	2	2 DG + DG2 + MG molecules [photographs, negative], undated
50	3	3 DG through brain barrier [photographs, negative], undated
50	4	4 functional anatomy of operational -- *DG equ. [photographs, negative], undated
50	5	5 lumped constant in several species [photographs, negative], undated
50	6	6 glucose utilization in conscious rat and monkey [photographs, negative], undated
50	7	7 effects of thiopental anesthesia on cerebral glucose utilization [photographs, negative], undated
50	8	8 spinal cord effects of unilateral stimulation [photographs, negative], undated
50	9	9 relationship between frequency of stimulation and LGU [photographs, negatives, slides], undated
50	10	10 focal seizure during LGU [photographs, negatives], undated
50	11	11 otitis [photographs, negatives], undated
50	12	12 left eye removed (rat) L.G.U. [photographs, negatives], undated
50	13	13 coronal brain (monkey) [photographs, negatives], undated
50	14	14 coronal brain (monkey) -- rt. eye occluded, undated
50	15	15 [negative], undated
50	16	16 12 hr. lt./12 hr. dk. (glucose utilization) [photographs, negative], undated
50	17	17 apomorphine rt. eye enucleated [photographs, negative], undated
50	18	18 effects of d- and 1- amphetamine on LCGU in rat [photographs, negative], undated
50	19	19 computer diagram image display system [photographs, negative], undated
50	20	20 average brain cerebral glucose utilization [negative], undated
50	21	21 ageing and metabolism [photographs, negative], undated
50	22	22 ageing and metabolism [photographs, negative], undated
50	23	23 ageing and metabolism, LCGU vs. apomorphine [photographs, negative], undated
50	24	24 ageing, LCGU vs. apomorphine [photographs, negative], undated
50	25	25 LCGU vs. aopmorphine (subthalamic nucleus and inferior olivary nucleus) [photographs, negative], undated
50	26	26 LCGU vs. apomorphine (ageing) [photographs, negative], undated
50	27	27 DG, FDG, CH3 -- glucose, brain pictures [photographs, negative], undated
50	28	28 glucose metabolic rate (FDG) [photographs, negative], undated
50	29	29 LCGU vs. apomorphine (age), undated
50	30	30 LCBF w/[I125] Hipdm vs. [C14} idoantipyrine [photographs, negative], undated
50	31	31 LCBF indicator fraction method [photographs, negative], undated
50	32	32 spreading depression [photographs, negative], undated
50	33	33 [photographs, negative], undated
50	34	34 electrical stimulation and DG* uptake in pituitary [negative], undated
50	35	35 socium pump and neurosecretion effects on DG* uptake [photographs, negative], undated
50	36	36 [125] hipdm and products vs. radioactivity in arterial blood [photographs, negative], undated
50	37	37 radioactivity DPM vs. time curves [photographs, negative], undated
50	38	38 spreading cortical depression (KCI) [photographs, negative], 1981
50	39	39 osmotic opening of BBB [photographs, negative], undated
50	40	40 blood flow vs. LGU in conscious and anesthetized [photographs, negative], undated
50	41	41 [photographs, negative], undated
50	42	42 glucose utilization in dark-adapted rats (saline vs. apomorphine) [photographs, negative], undated
50	43	43 dark-adapted rats (eye enucleated) saline vs. apomorphine [photographs, negative], undated
50	44	44 effects of light intensity on LGU [photographs, negative], undated
50	45	45 [125I] hipdm single pass extraction vs. venous [photographs, negative], undated
50	46	46 deosyglucose vs. glucose in arterial and venous [photographs, negative], undated
50	47-48	47 influence of rate constants on integrated pool specific activity [photographs, negative], undated
50	49	48 rate constants in the normal conscious albino rat [negative], undated
50	50	49 lump constant vs. time [photographs, negative], undated
50	51	50 cerebral metabolism of [14C] DG and G in vivo [photographs, negative], undated
50	52	51 blood CO2 curves [photographs, negative], undated
50	53	52 striate cortex (monkey) [photographs, negative], undated
50	54	53 autoradiograph dorsolateral surface of monkey occipital lobe [photographs, negative], undated
50	55	54 LCGU vs. apomorphine [photograph, negative, slides], undated
50	56	55 systems involved in higher functions [negative], undated
50	57	56 auditory system (LCGU) [negative], undated
50	58	57 auxtomy, leucine protein synthesis [photographs, negative], undated
50	59	58 auxtomy, DG, protein synthesis nissl stain [photographs, negative], undated
50	60	59 3H and 24C DG [photographs, negative], undated
50	61	60 brain anatomy labeled [photographs, negative], undated
50	62	61 experimental period effects on gray matter glucose utilization [photographs, negative], undated
50	63	62 visual stimulus (3H] DG [photographs, negative], undated
50	64	63 pretectal nucleus [photographs, negative], undated
50	65	64 visual cortex [photographs, negative], undated
50	66	65 lateral geniculate nucleus [photographs, negative], undated
50	67	66 posterolateral nucleus of the thalamus [photographs, negative], undated
50	68	67 blood flow vs. LCGU (control) [photographs, negative], undated
50	69	68 blood flow vs. LCGU (acidosis) [photographs, negative], undated
50	70	69 blood flow vs. LCGU (acidosis and control) [photographs, negative], undated
50	71	70 antidromic stimulation of superior cervical ganglion [photographs, negative], undated
50	72	71 superior colliculus LCGU vs. light intensity [photographs, negative], undated
50	73	72 *DG and *DG-6-phosphate concentration over time [photographs, negative], undated
50	74	73 antidomic stimulation of superior cervical ganglion [photographs, negative], undated
50	75	74 antidromic stimulation of superior cervical ganglion [photographs, negative], undated
50	76	75 air embolism and control in K+ concentration [photographs, negative], undated
50	77	76 air embolism and control in pH of injection fluid [photographs, negative], undated
50	78	78 post axotomy and control [photographs, negative], undated
50	79	80 [photographs, negative], undated
50	80	81 hypoxemia [photographs, negative], undated
50	81	82 darkness vs. 700 lux (pigmented rats) [photographs, negative], undated
50	82	83 hypoxemia [photographs, negative], undated
50	83	84 hypoxemia [photographs, negative], undated
50	84	85 darkness vs. 700 lux (albino rats) [photographs, negative], undated
50	85	86 newborn monkey [photographs, negative], undated
50	86	87 [photographs, negative], undated
50	87	88 spinal cord [photographs, negative], undated
50	88	89 globus pallidus, etc. [negative], undated
50	89	90 reginal glucose utilization [photographs, negative], undated
50	90	91 reginal glucose metabolism after 10 min. cerebral ischemia in the rat [photographs, negative], undated
50	91	92 [photograph], undated
50	92	93 left eye removed [photographs, negative], undated
50	93	94 penn. seizure antipyrine, baby monkey [photographs, negative], undated
50	94	95 effects of thiopental anesthesia on cerebral glucose utilization [photograph], undated
50	95	97 equilibration of glucose specific activity between plasma and brain [photographs, negative], undated
50	96	98 influence of duration on glucose utilization [photographs, negative], undated
50	97	99 relationship between stimulation and L.G.U. [photographs, negative], undated
50	98	100 determination of glucose specific activity [photographs, negative], undated
50	99	101 brain-plasma glucose equilibration, undated
50	100	102 tissue glucose pool 1/2 life vs. plasma glucose concentration [photographs, negative], undated
50	101	103 glucose activity in plasma, tissue [negative], undated
50	102	104 cerebral 02 consumption in cerebral blood flow [photographs, negative], undated
50	103	105 half-lives of DG*-6-P in grey and white matter [photographs, negative], undated
50	104	106 arterial and venous [ ] of 14c D.G. following i.v. in a cat [photographs, negative], undated
50	105	107 derivation of operational method for measurement of LCGU [photographs, negative], undated
50	106	108 tissue pool 1/2 life [photographs, negative], undated
50	107	109 math. analysis of model for total accumulation of DG* and DG*-P [photograph, negative], undated
50	108	110 theoretical calculation of [14c] DG-6-P in rat brain [photographs], undated
50	109	111 general equation + influence of phosphotase activity [photograph, negative], undated
50	110	112 lumped constant calculation used by Hawkins and Miller [photographs], undated
50	111	113 [photograph], undated
50	112	114 equation for changing plasma glucose concentration [photograph, negative], undated
50	113	115 BBB model and equation of 14C glucose uptake [photograph, negative], undated
50	114	116 glucose uptake model + equation [photographs, negative], undated
50	115	117 LCGU in conscious albino and pigmented rats [negative], undated
50	116	118 glucose utilization in sensorimotor systems [negative], undated
50	117	119 glucose utilization in myelinated fiber tracts [negative], undated
50	118	120 glucose utilization in limbic system [negative], undated
50	119	121 glucose utilization in conscious and restrained rats [negative], undated
50	120	122 glucose utilization of the visual system [negative], undated
50	121	123 1/2 life of tissue pool in male rats [negative], undated
50	122	124 turnover of tissue glucose pool in male rats [negative], undated
50	123	125 values of rate constants in normal conscious albino rats [photographs, negative], undated
50	124	127 conditions w/altered function in CNS w/out change in average body metabolism [photograph], undated
50	125	128 relationship between consciousness and cerebral metabolic rate [photograph], undated
50	126	129 sodium pump and neurosecretion effects on DG* uptake, undated
50	127	130 functional anatomy of the DG*method equ. [photographs, negative, slide], undated
50	128	131 operational equation of [14C] DG method [photographs, negatives], undated
50	129	132 plasm -- tissue B-B-B (revised by Smith) [photographs, negatives], undated
50	130	135 LCBF with hipdm indicator fractionation method [photographs, negatives], undated
50	131	136 [14c] glucose-6-P single pass extraction fraction [photographs, negatives], undated
50	132	137 LCBF w/[I125] hipdm tissue equilibration method [photographs, negatives], undated
50	133	138 retinal stimulation in rats [photographs, negatives], undated
50	134	139 local cerebral glucose utilization [photographs, negatives], undated
50	135	140 local cerebral blood flow [photographs, negatives], undated
50	136	141 kinetics of competitive substrate reactions [photographs, negatives], undated
50	137	142 CBF and CMR 02 vs. years [photographs, negatives], undated
50	138	143 influence of CO2 in correlation between LCBF and LCGU [photographs, negatives], undated
50	139	144 monkey [photographs, negatives], undated
50	140	145 glucose utilization vs. stimulation frequency [photographs, negatives], undated
50	141	146 operational equation of [14C] deoxyglucose method [photograph], undated
50	142	147 cervical ganglion drawing [photographs, negatives], undated
51	1	148 cervical ganglion drawing [photographs, negatives], undated
51	2	149 cervical ganglion (micro) [photographs, negatives], undated
51	3	150 effects of apomorphine upon glucose utilization in habenula [photographs, negatives], undated
51	4	151 LCGU vs. halperidol [photographs, negatives], undated
51	5	152 LCGU vs. apomorphine [photographs, negatives], undated
51	6	153 preanglionic holinergic fibers [photographs, negatives], undated
51	7	154 pre-ganglionic cholinergic [photographs, negatives], undated
51	8	155 focal seizures -- protein synthesis [photographs, negatives], undated
51	9	156 focal seizures (metabolic effects) [photographs, negatives], undated
51	10	157 optical density, apomorphine vs. halperidol [photographs, negatives], undated
51	11	158 apomorphine vs. haloperidol (magnification) [photographs, negatives], undated
51	12	159 slide to side differences in monkey brain structures [photographs, negatives], undated
51	13	160 LGU in monkey brain [photographs, negatives], undated
51	14	161 influence of age on responsiveness to apomorphine [photographs, negatives], undated
51	15	162 influence of age on responsiveness to apomorphine (zona compacta) [photographs, negatives], undated
51	16	163 influence of age on responsiveness to apomorphine (aged 48-67) [photographs, negatives], undated
51	17	164 cervical ganglion [photographs, negatives], undated
51	18	165 regional glucose utilization [photographs, negatives], undated
51	19	166 regional glucose utilization (ketamine) [photographs, negatives], undated
51	20	167 regional glucose utilization (limbic system) [photographs, negatives], undated
51	21	168 regional glucose utilization: auditory, visual, sensory [photographs, negatives], undated
51	22	169 physiologic pearmeters [photographs, negatives], undated
51	23	170 LCGU (percentage change from control) [photographs, negatives], undated
51	24	171 LCGU (percentage change from control) ketamine [photographs, negatives], undated
51	25	172 blood flow transport and metabolism [photographs, negatives], undated
51	26	173 SSA vs. 1/[GHB] [photographs, negatives], undated
51	27	174 SSA or NADPH vs. 1/[NADP+] [photographs, negatives], undated
51	28	175 SSA or NADPH vs. time [photographs, negatives], undated
51	29	176 1/[GHB] vs NADPH, NADPH vs. 1/[NADPH] [photographs, negatives], undated
51	30	177 NADPH vs. 1/[NADPH] and 1/[GHD] [photographs, negatives], undated
51	31	178 SA vs. [GHB] and [D-glucuronate] [photographs, negatives], undated
51	32	179 apomorphine substantia nigra young vs. aged rats [photographs, negatives], undated
51	33	180 monocular deprivation (neonatal monkey) [photographs, negatives], undated
51	34	181 naftidro furyl [photographs, negatives], undated
51	35	182 hypoxemia metabolic raes [photographs, negatives], undated
51	36	183 lateral genic (monkey) [photographs, negatives], undated
51	37	184 ketamine [photographs, negatives], undated
51	38	185 norepinephrine vs. LCGU [photographs, negatives], undated
51	39	186 norepinephrine vs. control LCGU [photographs, negatives], undated
51	40	187 LCGU in white matter during hypoxemia [photographs, negatives], undated
51	41	188 awake/asleep, striate cortex and sensory-motor cortex [photographs, negatives], undated
51	42	189 lumped constant vs. plasma glucose [photographs, negatives], undated
51	43	190 superior cervical ganglia/glucose utilization [photographs, negatives], undated
51	44	191 coeliac and cardiac ganglia/glucose utilization [photographs, negatives], undated
51	45	192 hexokinase synthesis chart [photographs, negatives], undated
51	46	193 physiological variables in hypoxemia [photographs, negatives], undated
51	47	194 average rate of G.U. in whole brain during hypoxemia [photographs, negatives], undated
51	48	195 captopril effects on G. U. of subfornical organ in Brattleboro rats [photographs, negatives], undated
51	49	196 deoxyglucose autoradiographs of cat lumbar spinal cord [photographs, negatives], undated
51	50	197 lumbar spinal cord + brain autoradiographs and stained [photographs, negatives], undated
51	51	198 hyperglycemia lumped constant [photographs, negatives], undated
51	52	199 time course of arterial and venous concentrations of DG* and G [photographs, negatives], undated
51	53	200 model for behavior of leucine in brain [photographs, negatives], undated
51	54	201 glucose clamp [photographs, negatives], undated
51	55	202 lumped constant at different plasma glucose levels, undated
51	56	203 conversion of leucine to acetoacetic acid and acetyl-coenzyme A [photographs, negatives], undated
51	57	204 metabolic rates during hypoxemia [photographs, negatives], undated
51	58	205 axotomy hypoglossal nucleus [photographs, negatives], undated
51	59	206 derivation of operational equ.-model I [photographs, negatives], undated
51	60	207 behavior of leucine in brain model [photographs, negatives], undated
51	61	208 differential equations leucine [photographs, negatives], undated
51	62	209 behavior of leucine in brain model 2 [photographs, negatives], undated
51	63	210 differential equations leucine II [photographs, negatives], undated
51	64	211 derivation of operational equ. -- model III [photographs, negatives], undated
51	65	212 leucine brain -- model III [photographs, negatives], undated
51	66	213 differential equations model III [photographs, negatives], undated
51	67	214 derivation of operational equ. model III [photographs, negatives], undated
51	68	215 derivation of operational equ. III continued [photographs, negatives], undated
51	69	216 derivation of equation [photographs, negatives], undated
51	70	217 model IV -- amino acid incorporation into protein [photographs, negatives], undated
51	71	218 derivation of operational equ. model IV [photographs, negatives], undated
51	72	219 derivation of operational equ. -- model IV continued [photographs, negatives], undated
51	73	220 lumped constant in hypoglycemia [photographs, negatives], undated
51	74	221 DG model -- intracellular and extracellular spaces [photographs, negatives], undated
51	75	222 LCGU kates of insulin-induced hypoglycemia rats [photographs, negatives], undated
51	76	224 physiological variables during insulin-induced hypoglycemia [photographs, negatives], undated
51	77	225 determination of the 1/2 life of the precursor leucine pool [photographs, negatives], undated
51	78	226 synthesis and catabolism of histamine, undated
51	79	227 determination of activity of L-leucine and TRNA-bound leucine [photographs, negatives], undated
51	80	228 scheme for oxidation of [ ]-yydroxybutyrate/ reduction of D-glucuranate [photographs, negative], undated
51	81	229 superior cervical ganglia (G.U. vs. time) [photographs, negative], undated
51	82	230 synaptic mechanisms for histamine neurons [photographs, negative], undated
51	83	231 visual cortex of monkey [photographs], undated
51	84	232 fetal sheep [photographs, negative], undated
51	85	233 fetal sheep? [photographs, negative], undated
51	86	234 saphenous nerve stimulation during anesthesia [photographs, negative], undated
51	87	235 monkey columns [photographs, negative], undated
51	88	236 norepinephrine vs. control LCGU [photographs, negative], undated
51	89	237 autradiographic resolutions [photographs, negative], undated
51	90	239 layer thickness 3H activity [photographs, negative], undated
51	91	240 LandR hemisphere [photographs, negative], undated
51	92	241 functional anatomy of the operational equ. of the 14c DG method [photographs, negative], undated
51	93	242 [photographs, negative], undated
51	94	243 [photographs, negative], undated
51	95	244 [photographs, negative], undated
51	96	245 olfactory bulbs [photographs, negative], undated
51	97	246 relative optical density [photographs, negative], undated
51	98	247 hot hole plug [photographs, negative], undated
51	99	248 brain standards 3H and 14c [photographs, negative], undated
51	100	249 goldfish retinas [photographs, negative], undated
51	101	250 somata cells labeled and unlabeled [photographs, negative], undated
51	102	251 cat muscle, 24c DG [photographs, negative], undated
51	103	252 3H DG water solution frozen in plasma [photographs, negative], undated
51	104	253 grain density in buccal ganglion [photographs, negative], undated
51	105	254 olfactory bulb in tiger salamander 3HDG [photographs, negative], undated
51	106	255 3HDG -- optic lobes of dorsophila melanogaster [photographs, negative], undated
51	107	256 relationship of aggression to onset of lidocaine seizures [photographs, negative], undated
51	108	257 autoradiographic calibration curves vs 3H concentration [photographs, negative], undated
51	109	258 [photographs, negative], undated
51	110	259 occular dominance newborn [photographs, negative], undated
51	111	260 position-emitting atom [photographs, negative], undated
51	112	261 [14C] and [3H] methylglucose [photographs, negative], undated
51	113	262 mid and posterior hypothalamus [photographs, negative], undated
51	114	263 anterior hypothalamus [photographs, negative], undated
51	115	264 dopamine pathways [photographs, negative], undated
51	116	265 integrated tissue specific activity [photographs, negative], undated
51	117	266 energy metabolism in the hypothalamus: effects of reproductive hormones [photographs, negative], undated
51	118	267 integrated tissue sp. ac. [photographs, negative], undated
51	119	268 integrated tissue sp. ac. [photographs, negative], undated
51	120	269 integrated tissue sp. ac. [photographs, negative], undated
51	121	270 GHB-dehydrogenase [photographs, negative], undated
51	122	271 GHB-dehydrogenase [photographs, negative], undated
51	123	272 GHB-dehydrogenase [photographs, negative], undated
51	124	273 GHB-dehydrogenase [photographs, negative], undated
51	125	274 GHB-dehydrogenase [photographs, negative], undated
51	126	275 ESN and WFN, Italy (Smith) [negatives], undated
51	127	276 columns in striate cortex (monkey) [photographs, negatives], undated
51	128	278 computer -- block diagram, undated
51	129	279 hypoxic rat injected with black microspheres, undated
51	130	280 dopaminerglic systems influence [photographs, negative], undated
51	131	281 apomorphine vs. saline on LGU [photographs, negative], undated
51	132	282 ocular dominance columns in monkey [photographs, negative], undated
51	133	283 effects of slow-wave sleep on LGU [photographs, negative], undated
51	134	284 subfornical organ in Battleboro [photographs, negative], undated
51	135	285 neural lobe LGU [photographs, negative], undated
51	136	286 two compartment model for the behavior of leucine brain -- model V [photographs, negative], undated
51	137	287 model VI for behavior of L-leucine in brain [photographs, negative], undated
51	138	288 GHB and GABA levels in rat brain [photographs, negative], undated
51	139	289 cytosol -- rat [photographs, negative], undated
51	140	290 GHB levels -- rat kidney [photographs, negative], undated
51	141	291 GHB dehydrogenase activity in rat kidney [photographs, negative], undated
51	142	292 GHB -- dehydrogenase activity in rat brain [photographs, negative], undated
51	143	293 apomorphine effect on different areas [photographs, negative], undated
51	144	294 superior cervical ganglion -- frequency [photographs, negative], undated
51	145	295 lump constant theoretical derivations [photographs, negative], undated
51	146	296 comparison -- LGU with 3H DG and 14C DG [photographs, negative], undated
51	147	298 bar test after morphine [photographs, negative], undated
51	148	299 morphine effect on LGU in brain [photographs, negative], undated
51	149	300 morphine effect on LGU in brain [photographs, negative], undated
51	150	301 fetal sheep [photographs, negative], undated
51	151	302 fetal sheep [photographs, negative], undated
51	152	303 morphine vs. control tail flick [photographs, negative], undated
51	153	304 average rate of GU for entire brain of fetal and newborn sheep, undated
51	154	305 chemical analysis of 14C DG and 14C DG-L-P in normal rats [photographs, negative], undated
51	155	306 extinction -- Icss [photographs, negative], undated
51	156	307 PCO2 and LCGU relationship [photographs, negative], undated
51	157	308 habenula afferent and efferent pathways [photographs, negative], undated
51	158	309 LGU in laboratory animals [photographs, negative], undated
51	159	310 time course of 14C DG and 14C DG-6-P [photographs, negative], undated
51	160	311 LGU and arterial PCO2 relationship [photographs, negative], undated
51	161	312 habenula and mammillary baby pathways [photographs, negative], undated
51	162	313 lateral habenula and mammillary baby pathways [photographs, negative], undated
51	163	314 [14C] deoxyglucose autoradiographs of cat brains [photographs, negative], undated
51	164	315 effect of acute morphine on GU in rat brain [photographs, negative], undated
51	165	315 effect of acute morphine on GU in rat brain [photographs, negative], undated
51	166	316 fetal sheep [photographs], undated
51	167	317 picture procedure, DG method [photographs, negative], undated
51	168	318 axotomy in hypoglossal nucleus [photographs, negative], undated
51	169	319 axotomy -- tongue functions [photographs, negative], undated
51	170	320 age-blood flow and 02 consumption [photographs, negative], undated
51	171	321 exchange of methylglucose between plasma and brain tissue [photographs, negative], undated
51	172	322 data analysis -- ipsilateral vs. contralateral [photographs, negative], undated
51	173	323 LGU stimulation pathway [photographs, negative], undated
51	174	324 3H standards calibration curves [photographs, negative], undated
51	175	325 visual deprivation protein synthesis [photographs, negative], undated
52	1	326 autoradiograph protein synthesis [photographs, negative], undated
52	2	327 LGU other connections [photographs, negative], undated
52	3	328 LGU: sensory-motor systems [photographs, negative], undated
52	4	329 LGU: forebrain terminal areas [photographs, negative], undated
52	5	330 electrode placements: contingent and non-contingent [photographs, negative], undated
52	6	331 electrode placements: stimulated and non-stimulated [photographs, negative], undated
52	7	332 3H methylglucose vs. 14C methylglucose [photographs, negative], undated
52	8	333 3H DG vs. 14C DG [photographs, negative], undated
52	9	334 morphine bar test and tail flick [photographs, negative], undated
52	10	335 [photographs, negative], undated
52	11	336 pineal body -- LGU monkey [photographs, negative], undated
52	12	337 diazepam -- LGU [photographs, negative], undated
52	13	338 TXW vs. control [photographs, negative], undated
52	14	339 cretin vs. control [photographs, negative], undated
52	15	340 TWX vs. control [photographs, negative], undated
52	16	341 physiological parameters -- day vs. night and sleep vs. awake [photographs, negative], undated
52	17	342 lesion -- lateral habenula -- LGU [photographs, negative], undated
52	18	343 fetal sheep [photographs, negative], undated
52	19	344 LGU in lateral habenula [photographs, negative], undated
52	20	348 GHB -- anaerobic and aerobic [photographs, negative], undated
52	21	349 neural structures regulating fluid balance [photographs, negative], undated
52	22	350 GHB dehydrogenase inhibitors on tissue levels of GHB [photographs, negative], undated
52	23	351 GHB -- synthesis and degradations pathways [photographs, negative], undated
52	24	352 distribution of radioactivity after various stages of fractionation [photographs, negative], undated
52	25	353 distribution of brain glycogen among fractions after extraction [photographs, negative], undated
52	26	354 brain extraction scheme 1 [photographs, negative], undated
52	27	355 brain extraction scheme 2 [photographs, negative], undated
52	28	356 histaminergic sites influence on cerebral vessels [photographs, negative], undated
52	29	357 neurotransmitter substances -- effect on pial arteriolar diameter [photographs, negative], undated
52	30	358 encaphalocoele vs. control, striate cortex of monkey [photographs, negative], undated
52	31	359 insulin -- effect on LGU [photographs, negative], undated
52	32	360 hyperglycemia vs. normal -- LGU [photographs, negative], undated
52	33	361 2-DG-6-PO4 and 2 DG-TLC of brain extracts [photographs, negative], undated
52	34	362 LGU in ganglia during stimulation (H2) in urethane anesthesia [photographs, negative], undated
52	35	363 probe track [photographs, negative], undated
52	36	364 VTA stimulation [photographs, negative], undated
52	37	365 VTA stimulation [photographs, negative], undated
52	38	366 amphetamine -- LGU [photographs, negative], undated
52	39	367 amphetamine -- locomotor and stereotypy scores [photographs, negative], undated
52	40	368 amphetamine [photographs, negative], undated
52	41	369 amphetamine [photographs, negative], undated
52	42	370 amphetamine [photographs, negative], undated
52	43	371 angiotensis II and saralasin [photographs, negative], undated
52	44	372 angiotensinard saralasin [photographs, negative], undated
52	45	373 apomorphine [photographs, negative], undated
52	46	374 apomorphine [photographs, negative], undated
52	47	375 subfornical organ and septal triangular N. -- LGU [photographs, negative], undated
52	48	376 subformical organ and septal tricular N. -- LGU [photographs, negative], undated
52	49	377 sheep LCGU -- pre and postnatal [photographs, negative], undated
52	50	378 caffeine -- LGU [photographs, negative], undated
52	51	379 caffeine -- LGU [photographs, negative], undated
52	52	380 EAS [photographs, negative], undated
52	53	381 female rats during cycle [photographs, negative], undated
52	54	382 electrical stimulation on pineal gland [photographs, negative], undated
52	55	383 female rats during cycle [photographs, negative], undated
52	56	384 model I -- leucine traveling BBB [photographs, negative], undated
52	57	385 percent change of protein synthesis, glucose utilization and relative twitch [photographs, negative], undated
52	58	386 glucose utilization in menstruating rats [photographs, negative], undated
52	59	387 postral calcarin fissure [photographs, negative], undated
52	60	388 optic radiation tract section [photographs, negative], undated
52	61	389 eye occlusion striate cortex [photographs, negative], undated
52	62	390 ambient light markings, striate cortex [photographs, negative], undated
52	63	391 eye occlusion lateral geniculate [photographs, negative], undated
52	64	392 general equ. for measurement of reaction rates with tracers [photographs, negative], undated
52	65	394 [125I] HIPDM and metabolic products in blood [photographs, negative], undated
52	66	395 molecular structure of HIPDM [photographs, negative], undated
52	67	396 [125I] HIPDM single pass extraction [photographs, negative], undated
52	68	397 super optical nucleus, salt loading [photographs, negative], undated
52	69	398 senescence [photographs, negative], undated
52	70	399 maturescence [photographs, negative], undated
52	71	400 LGU % change vs. stimulation frequency [photographs, negative], undated
52	72	401 sciatic nerve stim. LGU in spinal cord and dorsal root ganglia [photographs, negative], undated
52	73	402 water saturated vs. water deprived [photographs, negative], undated
52	74	403 water sated vs. H2O deprived [photographs, negative], undated
52	75	404 water sated vs. H2O deprived [photographs, negative], undated
52	76	405 self-stimulation chapter [photographs, negative], undated
52	77	406 self stim. cocaine/d-amphetamine/morphine [photographs, negative], undated
52	78	407 criteria for adequate psychophysical threshold determination [photographs, negative], undated
52	79	408 self stimulation [photographs, negative], undated
52	80	409 self stim. % response vs. ua [photographs, negative], undated
52	81	410 self stim. X Z score vs. dose [photographs, negative], undated
52	82	411 running speed vs. log pulses per reward [photographs, negative], undated
52	83	412 self-stimulation (graphic) [photographs, negative], undated
52	84	413 response rate vs. intensity (base line drug) [photographs, negative], undated
52	85	414a self stimulation pre/post responses [photographs, negative], undated
52	86	414b acute dehydration [photographs, negative], undated
52	87	415 acute dehydration [photographs, negative], undated
52	88	416 (spinal cord ) acute dehydration [photographs, negative], undated
52	89	417 adrenelectomy and dexamethason [photographs, negative], undated
52	90	418 nerve stimulation -- dorsal root ganglion [photographs, negative], undated
52	91	419 paraventricular nucleus -- acute adrenalectomy [photographs, negative], undated
52	92	420 dehydration [photographs, negative], undated
52	93	421 plasma and brain, deoxyglucose and deoxyglucose -- phosphate [photographs, negative], undated
52	94	422 arterial plasma DG*/G vs. time [photographs, negative], undated
52	95	423 pituitary neural lobe, water sated/water deprived [photographs, negative], undated
52	96	424 septal triangular nucleus [negative], undated
52	97	425 subfornical organ [photographs, negative], undated
52	98	426 latero-lateral habenula [photographs, negative], undated
52	99	427 spinal cord sciatic nerve stimulation [photographs, negative], undated
52	100	428 plasma concentration (arterial and venous) vs. time [photographs, negative], undated
52	101	429 pathways of glucose metabolism [photographs, negative], undated
52	102	430 uptake of [32P] glucose-6-phosphate [photographs, negative], undated
52	103	431 loss of label rates of [2-3H] glucose and [U14C] glucose in brain [photographs, negative], undated
52	104	432 electrical stim. of sciatic nerve on LGU in spinal cord [photographs, negative], undated
52	105	433 fractions of total tissue 14c content in form of free [14c] deoxyglucose in brain [photographs, negative], undated
52	106	434 time courses of [14c] DG and 14c DG-6-P, undated
52	107	435 measured and theoretical time courses of [14c] DG-6-P in brain [photographs, negative], undated
52	108	436 arteriovenous differences of [14c] glucose and [14c] DG [photographs, negative], undated
52	109	437 newborn lamb [photographs, negative], undated
52	110	438 comparative rates of loss of label from 2-[3H] glucose and, undated
52	111	439 nonacidic compounds w/vicinal cis diol. Groups [photographs, negative], undated
52	112	442 effects of fasting on tissue levels of GHB [photographs, negative], undated
52	113	443 biosynthesis of GHB by intact mitochondria [photographs, negative], undated
52	114	444 rates of glucose utilization in rat cervical ganglion [photographs, negative], undated
52	115	445 representative values for LCGU in conscious albino rat and monkey, undated
52	116	446 [photographs, negative], undated
52	117	447 cretin vs. control [photographs, negative], undated
52	118	448 parasaggittal blindspot [photographs, negative], undated
52	119	449 cretin vs. control [photographs, negative], undated
52	120	450 cretin vs. control [photographs, negative], undated
52	121	451 refused monkey cortical section [photographs, negative], undated
52	122	454 E-cat scan of normal brain after injection of [18-F] fluorodeoxyglucose[photographs, negative], undated
52	123	455 [photographs, negative], undated
52	124	456 3H/14C ration in blood glucose [photographs, negative], undated
52	125	457 pathways of GHB metabolism [photographs, negative], undated
52